<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26398</article-id><article-id pub-id-type="doi">10.7554/eLife.26398</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-82743"><name><surname>Wells</surname><given-names>Alexandria C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9799-8353</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82744"><name><surname>Daniels</surname><given-names>Keith A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82745"><name><surname>Angelou</surname><given-names>Constance C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82746"><name><surname>Fagerberg</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82747"><name><surname>Burnside</surname><given-names>Amy S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82748"><name><surname>Markstein</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82749"><name><surname>Alfandari</surname><given-names>Dominique</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0557-1246</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31149"><name><surname>Welsh</surname><given-names>Raymond M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-82750"><name><surname>Pobezinskaya</surname><given-names>Elena L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-82160"><name><surname>Pobezinsky</surname><given-names>Leonid A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6115-3559</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Veterinary and Animal Sciences</institution>, <institution>University of Massachusetts</institution>, <addr-line><named-content content-type="city">Amherst</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Pathology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Biology</institution>, <institution>University of Massachusetts</institution>, <addr-line><named-content content-type="city">Amherst</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dustin</surname><given-names>Michael L</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>pobezinskaya@umass.edu</email> (ELP);</corresp><corresp id="cor2"><email>lpobezinsky@umass.edu</email> (LAP)</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>07</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e26398</elocation-id><history><date date-type="received"><day>27</day><month>02</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>07</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Wells et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Wells et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-26398-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.26398.001</object-id><p>The differentiation of naive CD8 T cells into effector cytotoxic T lymphocytes upon antigen stimulation is necessary for successful antiviral, and antitumor immune responses. Here, using a mouse model, we describe a dual role for the let-7 microRNAs in the regulation of CD8 T cell responses, where maintenance of the naive phenotype in CD8 T cells requires high levels of let-7 expression, while generation of cytotoxic T lymphocytes depends upon T cell receptor-mediated let-7 downregulation. Decrease of let-7 expression in activated T cells enhances clonal expansion and the acquisition of effector function through derepression of the let-7 targets, including Myc and Eomesodermin. Ultimately, we have identified a novel let-7-mediated mechanism, which acts as a molecular brake controlling the magnitude of CD8 T cell responses.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.001">http://dx.doi.org/10.7554/eLife.26398.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>CTL</kwd><kwd>naive CD8 T cells</kwd><kwd>TCR</kwd><kwd>Eomes</kwd><kwd>Myc</kwd><kwd>metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000890</institution-id><institution>National Multiple Sclerosis Society</institution></institution-wrap></funding-source><award-id>PP-1503-03417</award-id><principal-award-recipient><name><surname>Pobezinsky</surname><given-names>Leonid A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008975</institution-id><institution>University of Massachusetts Amherst</institution></institution-wrap></funding-source><award-id>Start up funds</award-id><principal-award-recipient><name><surname>Pobezinsky</surname><given-names>Leonid A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>TCR-mediated downregulation of let-7 microRNAs licenses the differentiation of activated CD8 T cells into cytotoxic T lymphocytes.</meta-value></custom-meta><custom-meta><meta-name>eLife Digest</meta-name><meta-value>2.5</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>CD8 T cells are responsible for the rapid clearance of virally infected, and cancerous cells in the organism. Prior to encounter with antigen, naive CD8 T cells exhibit a quiescent state that is characterized by very low rates of proliferation, and a ‘quiet’ transcriptional landscape with no expression of any effector molecules. After antigen recognition, activated CD8 T cells undergo blastogenesis and rapid clonal expansion, which is followed by differentiation into effector cytotoxic T lymphocytes (CTLs), and memory T cells that are both capable of producing effector cytokines and killing target cells. These changes in T cells are accompanied by metabolic reprograming from oxidative phosphorylation to aerobic glycolysis that provides energy and larger amounts of the biomacromolecular intermediates needed to support growth (<xref ref-type="bibr" rid="bib71">Ward and Thompson, 2012</xref>).</p><p>The productive differentiation of CD8 T cells requires three definitive signals; one is from the T cell receptor (TCR) during antigen recognition, the second is from co-stimulation, and the third is due to cytokines. It has been extensively studied how these signals execute the CD8 T cell differentiation program by activation of a complex network of transcription factors such as Myc, Notch-1, T-bet, Eomes, Blimp-1, Zbtb32, Runx3, and Zeb2 (<xref ref-type="bibr" rid="bib3">Backer et al., 2014</xref>; <xref ref-type="bibr" rid="bib5">Best et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Pearce et al., 2003</xref>; <xref ref-type="bibr" rid="bib63">Szabo et al., 2000</xref>). However, the global regulation of these processes is not yet fully understood.</p><p>Post-transcriptional regulatory mechanisms provide broad regulation of gene expression. The most efficient post-transcriptional regulatory machinery involves RNA interference mediated by microRNAs (miRNAs), small non-coding RNAs that target mRNA in a sequence-specific manner to prevent protein synthesis, and the expression of which is both inducible, and tissue- specific (<xref ref-type="bibr" rid="bib4">Bartel, 2009</xref>; <xref ref-type="bibr" rid="bib26">Ha and Kim, 2014</xref>). The importance of this type of regulation for T cells was first demonstrated through the ectopic expression of various miRNAs during hematopoiesis (<xref ref-type="bibr" rid="bib10">Chen et al., 2004</xref>). Later, it was found that miRNA depletion achieved by a T-cell-specific deletion of Dicer, a critical enzyme involved in the biogenesis of mature miRNAs, resulted in severe defects, including aberrant proliferation, differentiation, and function of T lymphocytes (<xref ref-type="bibr" rid="bib14">Cobb et al., 2006</xref>, <xref ref-type="bibr" rid="bib13">Cobb et al., 2005</xref>; <xref ref-type="bibr" rid="bib48">Muljo et al., 2005</xref>). Further research corroborated these earlier studies, identifying the role of specific miRNAs in these processes. MiR-181 was shown to modulate TCR sensitivity and signal strength in developing and mature T cells (<xref ref-type="bibr" rid="bib28">Henao-Mejia et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Li et al., 2007</xref>). In CD4 T cells, miR-29 was shown to control the T helper response through the direct targeting of IFN-γ mRNA (<xref ref-type="bibr" rid="bib45">Ma et al., 2011</xref>), as well as the transcription factors T-bet and Eomes (<xref ref-type="bibr" rid="bib61">Steiner et al., 2011</xref>). In CD8 T cells, the upregulation of miR-130/301 (<xref ref-type="bibr" rid="bib80">Zhang and Bevan, 2010</xref>) and the miR-17–92 cluster (<xref ref-type="bibr" rid="bib61">Steiner et al., 2011</xref>; <xref ref-type="bibr" rid="bib37">Katz et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2012</xref>) was demonstrated to be essential for the initiation of differentiation upon antigen stimulation.</p><p>Let-7 miRNAs are the largest and most abundant family of miRNAs in lymphocytes, yet very little is know about their function. It has been shown that let-7 miRNAs are needed for the differentiation and function of natural killer T cells, an innate-like subset of T cells (<xref ref-type="bibr" rid="bib54">Pobezinsky et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Yuan et al., 2012</xref>). It has also been suggested that let-7 miRNAs may regulate T helper responses (<xref ref-type="bibr" rid="bib55">Polikepahad et al., 2010</xref>; <xref ref-type="bibr" rid="bib62">Swaminathan et al., 2012</xref>) and play a role in the suppressive function of Tregs (<xref ref-type="bibr" rid="bib51">Okoye et al., 2014</xref>). However, the extent to which let-7 miRNAs regulate the differentiation or function of CD8 T cells has yet to be explored.</p><p>In the present study, we examine the role of let-7 miRNA expression in naive and differentiating CD8 T cells. We found that in CD8 T cells high levels of let-7 miRNAs are necessary to maintain the naive phenotype, while TCR-mediated down-regulation of let-7 levels in activated cells is critical for the effective differentiation and function of CTLs. In fact, experimentally forced let-7 expression severely impairs the proliferation and differentiation of CD8 T cells, while let-7 deficiency significantly enhances the cytotoxic function of CTLs, and consequently immune responses in vivo. Given these findings, we propose a model in which let-7 acts as a molecular hub by converting the strength of TCR signaling into the strength of CD8 T cell function.</p></sec><sec id="s2" sec-type="results"><title>Results </title><sec id="s2-1"><title>let-7 miRNA expression maintains the quiescent state in naive CD8 T cells</title><p>To explore the potential regulatory role of let-7 miRNAs in CD8 T cells, the expression levels of let-7 miRNA family members in naive and activated CD8 T cells were determined and normalized to two different housekeeping RNAs. Surprisingly, the initially very high expression of let-7 miRNAs in naive CD8 T cells was reduced by TCR signaling, and this downregulation was proportional to the strength and duration of TCR-stimulation, regardless of housekeeping RNA used (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). As a specificity control, we confirmed the upregulation of miR-17 from the miR-17–92 locus (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>) that is induced upon T cell activation (<xref ref-type="bibr" rid="bib37">Katz et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2012</xref>). Taken together, these results suggest that TCR-mediated signaling inhibits the expression of let-7 miRNAs during T cell activation.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.002</object-id><label>Figure 1.</label><caption><title>let-7 expression is necessary and sufficient to maintain the naive phenotype of CD8 T cells prior to TCR stimulation.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive CD8 T cells stimulated with plate-bound anti-TCR (μg as indicated) and anti-CD28 (5 μg) for 24 hr, presented relative to results obtained for the small nuclear RNA (U6 control) and normalized to the unstimulated (0 μg) sample. (<bold>B</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive CD8 T cells stimulated with plate-bound anti-TCR (5 μg) and anti-CD28 (5 μg) over increasing periods of time as indicated, presented relative to results obtained for the small nuclear RNA (U6 control) and normalized to the unstimulated (0 hr) sample. (<bold>C</bold>) Size analysis based on FSC (forward scatter) of naive CD8 T cells from the spleens and lymph nodes of P14<sup>+</sup>wild-type and P14<sup>+</sup>Lin28Tg mice, both on <italic>Rag2<sup>−/−</sup></italic> background, normalized to wild-type. (<bold>D</bold>) Expression of Ki67 in naive CD8 T cells from spleens and lymph nodes of P14<sup>+</sup>wild-type and P14<sup>+</sup>Lin28Tg mice, both on <italic>Rag2<sup>−/−</sup></italic> background (left). Quantification of the frequency of Ki67<sup>+</sup> cells in these populations (right). (<bold>E</bold>) Frequency of BrdU<sup>+</sup> cells in naive CD8 T cells from spleens and lymph nodes of P14<sup>+</sup>wild-type (n = 6) and P14<sup>+</sup>Lin28Tg (n = 5) mice, both on <italic>Rag2<sup>−/−</sup></italic> background, labeled with BrdU in vivo. *p&lt;0.05, **p&lt;0.01,***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test. Data are one experiment representative of three independent experiments (a, b; mean and s.e.m. of technical triplicates; c, d; mean and s.e.m. of three experiments).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.002">http://dx.doi.org/10.7554/eLife.26398.002</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.26398.003</object-id><label>Figure 1—source data 1.</label><caption><title>Quantification of the expression of miRNAs by qPCR, and flow cytometry analysis of the phenotype of naive CD8 T cells.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.003">http://dx.doi.org/10.7554/eLife.26398.003</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>let-7 expression is downregulated upon TCR stimulation in CD8 T cells.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive CD8 T cells stimulated with plate-bound anti-TCRβ (μg as indicated) and anti-CD28 (5 μg) for 24 hr (from <xref ref-type="fig" rid="fig1">Figure 1A</xref>), presented relative to results obtained for the small nuclear RNA (U6 control) and normalized to the unstimulated (0 μg) sample, and displayed as individual miRNAs. (<bold>B</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive CD8 T cells stimulated with plate-bound anti-TCRβ (5 μg) and anti-CD28 (5 μg) over increasing periods of time as indicated (from <xref ref-type="fig" rid="fig1">Figure 1B</xref>), presented relative to U6 control and normalized to the unstimulated (0 hr) sample, and displayed as individual miRNAs. n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with 0 μg (<bold>A</bold>) or 0 hr (<bold>B</bold>) using two-tailed Student’s <italic>t</italic>-test (<bold>A, B</bold>). Data are one experiment representative of three independent experiments (b; mean and s.e.m. of technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.004">http://dx.doi.org/10.7554/eLife.26398.004</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>TCR-mediated regulation of miRNA expression.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive CD8 T cells stimulated with plate-bound anti-TCRβ (10 μg) and anti-CD28 (5 μg) over increasing periods of time as indicated, presented relative to results obtained for the small nucleolar RNA (sno135) and normalized to the unstimulated (0 hr) sample. (<bold>B</bold>) Quantitative RT-PCR analysis of miR-17 in naive CD8 T cells stimulated with plate-bound anti-TCRβ (10 μg) and anti-CD28 (5 μg) over increasing periods of time as indicated, presented relative to results obtained for the small nuclear RNA (U6) (left) or the small nucleolar RNA (sno135) (right) and normalized to the unstimulated (0 hr) sample. ***p&lt;0.001, compared with 0 hr using two-tailed Student’s <italic>t</italic>-test (<bold>B</bold>). Data are from one experiment representative of two independent experiments (a, b; mean and s.e.m. of technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.005">http://dx.doi.org/10.7554/eLife.26398.005</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig1-figsupp2-v2"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Expression of let-7 and activation markers in P14<sup>+</sup> CD8 T cells.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive and effector (day 5) TCR transgenic CD8 T cells from P14<sup>+</sup><italic>Rag2<sup>−/−</sup></italic>, and P14<sup>+</sup>Lin28Tg<italic>Rag2<sup>-/−</sup></italic> mice. (<bold>B</bold>) Surface expression (right) and normalized MFI (left) of CD25, CD44 and CD122 on naive CD8 T cells from both spleens and lymph nodes of P14<sup>+</sup>wild-type and P14<sup>+</sup> Lin28Tg mice, both on <italic>Rag2<sup>−/−</sup></italic> background. Gray indicates an isotype control for staining. n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test (<bold>B</bold>). Data are from one experiment representative of three independent experiments (a; mean and s.e.m. of technical triplicates; b, c; mean and s.e.m. of three experiments).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.006">http://dx.doi.org/10.7554/eLife.26398.006</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig1-figsupp3-v2"/></fig></fig-group></p><p>To determine the functional significance of let-7 expression in naive CD8 lymphocytes, we examined CD8 T cells from P14<sup>+</sup>Lin28Tg<italic>Rag2</italic><sup>−/−</sup> mice where T-cell-specific expression of the Lin28 protein blocks let-7 biogenesis (<xref ref-type="bibr" rid="bib54">Pobezinsky et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Piskounova et al., 2011</xref>), inhibiting let-7 expression, and P14 is a monoclonal T cell receptor specific to the lymphocytic choriomeningitis virus (LCMV) peptide gp33-41, presented in the context of H-2D<sup>b</sup> molecules (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). In comparison to the P14<sup>+</sup>wild-type counterparts, P14<sup>+</sup>Lin28Tg CD8 T cells were significantly larger in size, with a dramatically increased proportion of Ki67-positive cells (<xref ref-type="bibr" rid="bib15">Cuylen et al., 2016</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>). Consistent with the increased proportion of Ki67-positive cells, P14<sup>+</sup>Lin28Tg mice had a significantly higher frequency of BrdU-positive cells in both the spleen and lymph nodes, as compared to P14<sup>+</sup>wild-type mice (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). In addition, surface expression of T cell activation markers, such as the IL-2 receptor beta-chain (CD122), and CD44 was also increased, while cells remained CD25 negative (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). Thus, these results suggest that the expression of let-7 miRNAs may maintain the quiescent state in naive CD8 T cells.</p></sec><sec id="s2-2"><title>let-7 miRNA expression in CTLs affects both the antiviral and antitumor immune responses</title><p>TCR stimulation of naive T cells leads to a rapid loss of the quiescent state and differentiation into effector cells. Given that the expression of let-7 miRNAs, which is critical for the maintenance of naive CD8 T cells, is inhibited by TCR signaling (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>), we hypothesized that the downregulation of let-7 miRNAs in response to TCR stimulation is necessary for the differentiation and function of effector CD8 T cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.007</object-id><label>Figure 2.</label><caption><title>Inhibitory role of let-7 miRNA expression in CD8 T-cell-mediated responses in vivo.</title><p>(<bold>A</bold>) Schematic representation of the hypothesis that let-7 expression inhibits the differentiation of CD8 T cells. (<bold>B</bold>) Quantification of the number of donor (CD45.2<sup>+</sup>) CD8 T cells from P14<sup>+</sup>wild-type (n = 3) or P14<sup>+</sup>let-7Tg mice (n = 3) in the spleens of congenic (CD45.1<sup>+</sup>) host mice 7 days after cell transfer and LCMV Armstrong infection. (<bold>C</bold>) Surface expression of the activation marker KLRG1 on wild-type host, and indicated donor cells (top). Expression of IFN-γ, and TNF-α in wild-type host, and donor LCMV-specific CD8 T cells from the indicated mice, as determined by re-stimulation with the gp33 peptide, and subsequent intracellular staining (middle). Quantification of the frequency of KLRG1<sup>+</sup>, and IFN-γ<sup>+</sup>, TNF-α<sup>+</sup> populations in wild-type host, and donor cells from the indicated mice (bottom). (<bold>D</bold>) Analysis of the survival of wild-type (n = 5) or let-7Tg (n = 5) mice injected i.p. with 30 × 10<sup>6</sup> P815 cells. (<bold>E</bold>) Quantification of the number of P815 tumor cells remaining in the peritoneal cavity 7 days after i.p. injection of 20 × 10<sup>6</sup> cells into either wild-type (n = 6), or let-7Tg mice (n = 5). n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test (<bold>B, C, D</bold>) or one-tailed Student’s <italic>t</italic>-test (<bold>E</bold>). Data are from one experiment representative of three independent experiments (b, c; mean and s.e.m. of technical triplicates), or two experiments (<bold>D,E</bold>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.007">http://dx.doi.org/10.7554/eLife.26398.007</ext-link></p><p><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.26398.008</object-id><label>Figure 2—source data 1.</label><caption><title>Quantification of let-7 expression by qPCR, and flow cytometry analysis of effector CD8 T cells during the response to LCMV infection.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.008">http://dx.doi.org/10.7554/eLife.26398.008</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>P815 (H-2d) tumor rejection is mediated by CD8 T cells in H-2b mice.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive and effector (day 5) TCR transgenic CD8 T cells from P14<sup>+</sup><italic>Rag2<sup>−/−</sup></italic>, and P14<sup>+</sup>let-7Tg<italic>Rag2<sup>−/−</sup></italic> mice (<bold>B</bold>) Analysis of the survival of <italic>Rag2<sup>−/−</sup></italic> mice injected i.p. with 30 × 10<sup>6</sup> P815 cells, which received i.v. adoptive transfer of 10 × 10<sup>6</sup> naïve purified CD8 T cells (n = 6) or no T cells at all (n = 8). Data are from one experiment representative of three independent experiments (a; mean and s.e.m. of technical triplicates) or one experiment (<bold>B</bold>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.009">http://dx.doi.org/10.7554/eLife.26398.009</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig2-figsupp1-v2"/></fig></fig-group></p><p>To determine whether TCR-mediated downregulation of let-7 miRNAs is required for CD8 T cell differentiation in vivo, we analyzed the fate of P14<sup>+</sup> CD8 T cells with forced let-7 expression in response to acute viral infection with LCMV Armstrong. The doxycycline-inducible let-7g transgene (<xref ref-type="bibr" rid="bib81">Zhu et al., 2011</xref>) maintains let-7g miRNA expression in lymphocytes in the presence of doxycycline, even after TCR stimulation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Donor CD45.2<sup>+</sup>CD8<sup>+</sup> T cells from P14<sup>+</sup> and P14<sup>+</sup> let-7 transgenic (let-7Tg) mice were adoptively transferred into host congenic wild-type CD45.1<sup>+</sup> mice that were concurrently infected with LCMV, and the differentiation state of P14<sup>+</sup> cells was assessed 7 days post- injection. Interestingly, the recovery of donor CD8 T cells at the peak of the immune response revealed that P14<sup>+</sup>let-7Tg CD8 T cells failed to clonally expand (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and lacked KLRG1 expression, an established marker of terminal effector CTLs (<xref ref-type="bibr" rid="bib16">Dominguez et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Joshi et al., 2007</xref>; <xref ref-type="bibr" rid="bib65">Thimme et al., 2005</xref>; <xref ref-type="bibr" rid="bib68">Voehringer et al., 2001</xref>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Furthermore, let-7Tg CTLs had a reduced frequency of IFN-γ<sup>+</sup>TNF-α<sup>+</sup> cytokine double-producing cells, a hallmark of an effective CD8 T cell response (<xref ref-type="bibr" rid="bib34">Kaech et al., 2002</xref>; <xref ref-type="bibr" rid="bib73">Wherry and Ahmed, 2004</xref>; <xref ref-type="bibr" rid="bib75">Williams and Bevan, 2007</xref>), while the differentiation of endogenous host-derived CTLs was normal, suggesting a cell-intrinsic mechanism (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Importantly, mRNAs of the <italic>Klrg1</italic>, <italic>Ifng</italic> and <italic>Tnfa</italic> genes are not targets of let-7 miRNAs, therefore the reduced frequencies of effector cells generated from let-7Tg CD8 T cells is not simply a result of direct suppression of effector molecule expression. Thus, sustained let-7 expression following TCR activation severely impaired the clonal expansion and differentiation of CTLs in response to viral infection in vivo.</p><p>As the allogeneic response to foreign MHC is one of the most robust responses of the immune system, we further aimed to determine whether steady levels of let-7 in T cells would suppress the allogeneic response in vivo (<xref ref-type="bibr" rid="bib19">Felix and Allen, 2007</xref>; <xref ref-type="bibr" rid="bib31">Janković et al., 2002</xref>). We used the P815 mastocytoma, an allogeneic (H-2d haplotype) tumor, that has been shown to elicit a CD8 T-cell-mediated allogeneic immune response (<xref ref-type="bibr" rid="bib79">Zhan et al., 2000</xref>). We confirmed this by demonstrating that P14<sup>+</sup><italic>Rag2</italic><sup>−/−</sup> mice failed to reject the tumor without adoptive transfer of CD8 T cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Interestingly, when the P815 cells were injected into wild-type or let-7Tg mice of H-2b haplotype, 60% of let-7Tg mice were unable to effectively respond to, and clear the tumor (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Additionally, at 7 days post-injection, wild-type mice retained on average 40 × 10<sup>6</sup> cancer cells in the peritoneal cavity, while let-7Tg mice contained 115 × 10<sup>6</sup> cancer cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). We concluded that CD8 T cells that maintained let-7 expression upon stimulation and differentiation had a compromised response to the alloantigen, and thus failed to reject P815 tumor cells. Taken together, our results demonstrate that the decrease in let-7 expression upon TCR activation is necessary for the proper proliferation and differentiation of cytotoxic CD8 T cells in vivo.</p></sec><sec id="s2-3"><title>Expression of let-7 miRNAs in activated CD8 T cells inhibits proliferation and the gene expression program responsible for the metabolic switch</title><p>To elucidate the underlying mechanisms of let-7-mediated suppression of CD8 T-cell responses (<xref ref-type="fig" rid="fig2">Figure 2</xref>), we first analyzed the impact of let-7 miRNAs on T cell clonal expansion. Sorted naive (CD44<sup>lo</sup>CD25<sup>-</sup>) CD8 T cells with different levels of let-7 expression (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>) were activated with anti-CD3 mAbs in vitro for 3 days. Interestingly, let-7Tg CD8 T cells proliferated less than their wild-type counterparts, while Lin28Tg CD8 T cells exhibited enhanced proliferation (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These results indicate that let-7 miRNAs negatively regulate clonal expansion of activated CD8 T cells, which is consistent with our previous results in vivo (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Thus, we concluded that TCR-mediated downregulation of let-7 expression is needed for successful proliferation of activated CD8 T cells.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.010</object-id><label>Figure 3.</label><caption><title>let-7 miRNAs suppress the proliferation and metabolism of activated CD8 T cells.</title><p>(<bold>A</bold>) Analysis of the proliferation of CellTrace Violet-labeled naive CD8 T cells from the indicated mice 72 hr after activation with anti-CD3 mAbs. (<bold>B</bold>) Quantitative RT-PCR analysis of cell cycle regulators: <italic>Cdc25a</italic> (Cell division cycle 25A phosphatase), <italic>Ccnd2</italic> (Cyclin D2), <italic>Ccnf</italic> (Cyclin F), <italic>Cdk6</italic> (Cyclin dependent kinase 6) in naive and activated wild-type, let-7Tg, and Lin28Tg CD8 T cells 3 days after anti-CD3 mAb stimulation, presented relative to the ribosomal protein <italic>Rpl13a</italic>. (<bold>C</bold>) Quantitative RT-PCR analysis of <italic>Myc</italic> and <italic>Tfap4</italic> (Transcription factor AP-4) in CD8 T cells after stimulation with anti-CD3 mAbs, presented relative to the ribosomal protein <italic>Rpl13a</italic>. Wild-type, let-7Tg, and Lin28Tg CD8 T cells were stimulated with anti-CD3 mAbs and differentiated for the indicated time. (<bold>D</bold>) Quantitative RT-PCR analysis of the expression of genes involved in the metabolic switch: <italic>Glut1</italic> (Glucose transporter 1), <italic>Glut3</italic> (Glucose transporter 3), <italic>Gpd2</italic> (Glycerol-3-phosphate dehydrogenase 2), <italic>Pfk1</italic> (Phosphofructokinase 1), <italic>Hk2</italic> (Hexokinase 2), <italic>Tpi</italic> (Triose phosphate isomerase), <italic>Pkm</italic> (Pyruvate kinase muscle isozyme), <italic>Ldha</italic> (Lactate dehydrogenase A), <italic>Yars</italic> (Tyrosyl-tRNA synthetase) in wild-type, let-7Tg, and Lin28Tg CD8 T cells 3 days after stimulation with anti-CD3 mAbs, presented relative to the ribosomal protein, <italic>Rpl13a</italic>. n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test. (a, b, c, d; one experiment representative of three independent experiments (a) or mean and s.e.m. of technical triplicates (b, c, d)).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.010">http://dx.doi.org/10.7554/eLife.26398.010</ext-link></p><p><supplementary-material id="SD3-data"><object-id pub-id-type="doi">10.7554/eLife.26398.011</object-id><label>Figure 3—source data 1.</label><caption><title>Quantification of the expression of cell cycle regulators, <italic>Myc</italic> and <italic>Tfap4</italic>, metabolic enzymes, and let-7 miRNAs by qPCR.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.011">http://dx.doi.org/10.7554/eLife.26398.011</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.012</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Sorting strategy and let-7 expression in polyclonal CD8 T cells.</title><p>(<bold>A</bold>) Pre- sort and post- sort purities for naive CD8 T cells from wild-type, let-7Tg, and Lin28Tg mice. Cells were isolated from the lymph nodes of the indicated mice, and enriched for T cells using anti-mouse IgG magnetic beads. Next, to acquire naive CD8 T cells, lymph node T cells were then stained for CD25, CD44, CD4, and CD8, and sorted as the CD25<sup>-</sup>CD44<sup>lo</sup>CD4<sup>-</sup>CD8<sup>+</sup> population. (<bold>B</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in naive and activated (day 5) polyclonal CD8 T cells from wild-type, let-7Tg, and Lin28Tg mice.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.012">http://dx.doi.org/10.7554/eLife.26398.012</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig3-figsupp1-v2"/></fig></fig-group></p><p>Let-7 miRNAs are well-documented tumor suppressors. It has been shown that let-7 inhibits proliferation in cancerous cells by directly targeting the mRNA of genes that are involved in the regulation of the cell cycle (<xref ref-type="bibr" rid="bib32">Johnson et al., 2007</xref>). In fact, the expression of some let-7 targets such as phosphatase cdc25a (<italic>cdc25a</italic>), kinase cdk6 (<italic>cdk6</italic>), and cyclin D2 (<italic>ccnd2</italic>), was suppressed in activated let-7Tg CD8 T cells, as compared to Lin28Tg CD8 T cells where it was derepressed (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). It has been shown that let-7 may also regulate the transcription factor Myc, expression of which is upregulated upon T cell activation and is essential for CD8 T cell proliferation (<xref ref-type="bibr" rid="bib5">Best et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Iritani et al., 2002</xref>; <xref ref-type="bibr" rid="bib40">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib50">Nie et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Verbist et al., 2016</xref>). Interestingly, activated let-7Tg CD8 T cells had reduced expression of Myc, whereas let-7-deficient (Lin28Tg) CD8 T cells had increased Myc expression (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). To demonstrate that Myc activity was suppressed by let-7, we also analyzed the expression of a direct transcriptional target of Myc, the transcription factor AP4 (<italic>Tfap4)</italic>, which sustains Myc-mediated effects in CD8 T cells during the later stages of differentiation (<xref ref-type="bibr" rid="bib12">Chou et al., 2014</xref>). Although mRNA of the <italic>Tfap4</italic> gene is not a target of let-7, the expression of <italic>Tfap4</italic> mRNA was significantly reduced in let-7Tg CD8 T cells, and enhanced in Lin28Tg CD8 T cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), suggesting that let-7 regulates Myc activity in CD8 T cells.</p><p>Another important function of Myc in activated CD8 T cells is to support the proliferative burst through the metabolic reprogramming of lymphocytes from primarily oxidative phosphorylation (resting) to glycolysis (activated), as well as through an increase in protein synthesis (<xref ref-type="bibr" rid="bib8">Cham et al., 2008</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2011</xref>). To test whether let-7 miRNAs have an impact on the metabolic switch in activated CD8 T cells through its regulation of Myc, we assessed the expression of key glucose transporters, glycolytic enzymes, and protein synthesis enzymes that have been established as direct targets of Myc in activated CD8 T cells (<xref ref-type="bibr" rid="bib69">Wang et al., 2011</xref>). Strikingly, the expression of all tested targets was suppressed in let-7 transgenic CD8 T cells, and increased in Lin28Tg-activated lymphocytes, suggesting that let-7 expression may influence Myc-dependent metabolic reprogramming of activated CD8 T cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Taken together, these results demonstrate that let-7 miRNAs control the proliferation of activated CD8 T cells by modulating the expression and activity of genes that are involved in the regulation of the cell cycle and metabolism.</p></sec><sec id="s2-4"><title>let-7 expression regulates the function of differentiated CD8 T cells</title><p>To identify whether let-7-mediated suppression of CD8 T cell immune responses is due to a failure to acquire effector function in addition to a proliferative defect, we assessed the cytotoxic activity of CTLs generated from P14<sup>+</sup>wild-type, P14<sup>+</sup>let-7Tg, and P14<sup>+</sup>Lin28Tg mice. In fact, the expression of the let-7 transgene in P14<sup>+</sup> CTLs greatly diminished their cytotoxic activity (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Alternatively, P14<sup>+</sup>Lin28Tg CTLs exhibited enhanced cytotoxicity (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), which could be reduced by restoring let-7 expression through the induction of the doxycycline-inducible let-7 transgene in P14<sup>+</sup>let-7TgLin28Tg (4 Tg) CTLs (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), demonstrating that let-7 deficiency, and not Lin28 overexpression, is responsible for increased cytotoxicity. Thus, we demonstrated that TCR-mediated downregulation of let-7 microRNAs is necessary for the acquisition of cytotoxic function in differentiating CD8 T cells.<fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.013</object-id><label>Figure 4.</label><caption><title>let-7 miRNAs negatively regulate differentiation and acquisition of effector function in CTLs.</title><p>(<bold>A, B</bold>) Cytotoxicity assay of differentiated CTLs from P14<sup>+</sup>wild type, P14<sup>+</sup>let-7Tg, and P14<sup>+</sup>Lin28Tg lymph nodes (<bold>A</bold>) or from P14<sup>+</sup>wild-type (WT), or P14<sup>+</sup>let-7Tg<sup>+</sup>Lin28Tg<sup>+</sup><italic>Rag2<sup>−/−</sup></italic> (4Tg) lymphocytes co-cultured with either LCMV gp33 or LCMV np396 peptide-pulsed splenocytes for 4–5 hr, either in the presence or absence of doxycycline (<bold>B</bold>). (<bold>C</bold>) Analysis of the internal complexity (FSC, forward scatter; SSC, side scatter) of effector (5 days after anti-CD3 mAb stimulation) CD8 T cells generated from wildtype, let-7Tg, and Lin28Tg lymphocytes (left) and quantification of SSC of CD8 T cells normalized to wild-type. (<bold>D</bold>) Quantification of Granzyme A and Granzyme B- positive granules in wild-type, let-7Tg, and Lin28Tg CTLs via MilliPore Amnis ImageStream. (<bold>E</bold>) Quantitative RT-PCR analysis of effector molecule mRNA expression: <italic>Gzma</italic> (Granzyme A), <italic>Gzmb</italic> (Granzyme B), <italic>Prf1</italic> (Perforin) in naive and effector CD8 T cells from wild-type, let-7Tg, and Lin28Tg lymph nodes, presented relative to expression of the ribosomal protein <italic>Rpl13a</italic>. (<bold>F</bold>) Staining (top, middle) and MFI (bottom) of Granzyme B, Interferon-γ, and Granzyme A in wild-type, let-7Tg, and Lin28Tg effector CD8 T cells normalized to wild type. (<bold>G</bold>) Western blot analysis of lysates of wild-type, let-7Tg, and Lin28Tg effector CD8 T cells, probed with monoclonal antibodies against Perforin and actin. n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test. Data are from one experiment representative of three experiments (a, b, e; mean and s.e.m. of technical triplicates, f; mean and s.e.m of three experiments).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.013">http://dx.doi.org/10.7554/eLife.26398.013</ext-link></p><p><supplementary-material id="SD4-data"><object-id pub-id-type="doi">10.7554/eLife.26398.014</object-id><label>Figure 4—source data 1.</label><caption><title>Quantification of cytotoxic assays and expression of effector molecules assessed by qPCR and flow cytometry in CTLs.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.014">http://dx.doi.org/10.7554/eLife.26398.014</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.015</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Effector molecule mRNA expression in 4Tg mice.</title><p>Quantitative RT-PCR analysis of effector molecule mRNA expression: <italic>Prf1</italic> (Perforin), <italic>Gzma</italic> (Granzyme A), <italic>Gzmb</italic> (Granzyme B) in effector CD8 T cells from P14<sup>+</sup>wild-type, or P14<sup>+</sup>let-7Tg<sup>+</sup>Lin28Tg<sup>+</sup><italic>Rag2<sup>−/−</sup></italic> (4Tg) lymph nodes cultured either in the presence or absence of Dox (doxycycline), presented as the fold change in expression, normalized to wild-type. ***p&lt;0.001, 4Tg without Dox compared with 4Tg with Dox using two-tailed Student’s <italic>t</italic>-test. Data are from one experiment (mean and s.e.m. of technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.015">http://dx.doi.org/10.7554/eLife.26398.015</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig4-figsupp1-v2"/></fig></fig-group></p><p>To investigate the mechanism of how let-7 miRNA expression impacts CD8 T cell function, we examined the phenotype of in vitro generated effector CTLs from wild-type, let-7Tg, and Lin28Tg mice. Let-7Tg CTLs had less internal complexity based on the intensity of side scatter (SSC) than wild-type cells, whereas Lin28Tg CD8 effector cells had significantly greater complexity (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), suggesting a change in the number of cytotoxic granules. Indeed, let-7Tg CTLs contained fewer Granzyme A and Granzyme B positive granules than wild-type CTLs, while Lin28Tg CTLs had more (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These results indicated that the expression of let-7 controls the quantity of cytotoxic granules produced during the differentiation of CTLs.</p><p>Next, to determine whether let-7 expression in CTLs influences the number of granules by controlling the expression of effector molecules, gene expression of Granzyme A (<italic>Gzma</italic>), Granzyme B (<italic>Gzmb</italic>), and Perforin (<italic>Prf1</italic>), the key cytolytic factors in cytotoxic granules (<xref ref-type="bibr" rid="bib27">Hayes et al., 1989</xref>; <xref ref-type="bibr" rid="bib43">Lancki et al., 1991</xref>), was measured. Let-7Tg CTLs, which contained fewer cytotoxic granules, expressed less mRNA for <italic>Gzma</italic>, <italic>Gzmb</italic>, and <italic>Prf1</italic>, as compared to wild-type cells, while Lin28Tg CTLs had higher expression of these effector molecules (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Moreover, the observed changes in mRNA expression of effector molecules, including Interferon-gamma (IFN-γ), were consistent at the protein level (<xref ref-type="fig" rid="fig4">Figure 4F,G</xref>). Importantly, the induction of let-7 expression in the presence of Lin28 in P14<sup>+</sup>let-7TgLin28Tg (4 Tg) CTLs reduced the expression of these effector molecules (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), again demonstrating that enhanced effector molecule expression is due to let-7 deficiency. Together, these data indicate that let-7 miRNAs negatively regulate CTL function by preventing the expression of important cytotoxic molecules.</p></sec><sec id="s2-5"><title>let-7 miRNAs directly target the ‘master regulator’ transcription factor, Eomesodermin during CTL differentiation</title><p>To determine how let-7 regulates the differentiation and function of CTLs, we considered the possibility that let-7 miRNAs may directly regulate the expression of effector molecules. Although typical miRNA-binding sites are found in the 3’ untranslated regions (UTRs) of mRNA transcripts (<xref ref-type="bibr" rid="bib42">Lai, 2002</xref>; <xref ref-type="bibr" rid="bib56">Reinhart et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">Wightman et al., 1993</xref>), we analyzed the full length mRNA of <italic>Prf1</italic>, <italic>Gzma</italic>, <italic>Gzmb</italic>, and <italic>Ifng</italic>, yet no let-7-binding sites were found. This suggested that let-7 may indirectly regulate the expression of these molecules by controlling more global regulators, such as transcription factors. It is known that the expression of effector molecules and cytotoxic function of CD8 T cells are tightly regulated by a group of transcription factors, including Eomesodermin (Eomes), T-bet, Zbtb32, Runx3, Notch-1 and Blimp-1 (<xref ref-type="bibr" rid="bib3">Backer et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Pearce et al., 2003</xref>; <xref ref-type="bibr" rid="bib11">Cho et al., 2009</xref>; <xref ref-type="bibr" rid="bib35">Kallies et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Rutishauser et al., 2009</xref>; <xref ref-type="bibr" rid="bib64">Szabo et al., 2002</xref>; <xref ref-type="bibr" rid="bib60">Shin et al., 2014</xref>). To determine if these factors are regulated by let-7, relative gene expression in CTLs with different levels of let-7 was assessed for <italic>Eomes</italic>, <italic>Tbx21</italic>, <italic>Zbtb32</italic>, <italic>Prdm1</italic>, <italic>Runx3d</italic> and Notch-1 genes. The only transcription factor whose expression on both the mRNA and protein levels was reduced in let-7Tg CTLs, and enhanced in Lin28Tg CTLs, was <italic>Eomes</italic> (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,B</xref>). Furthermore, the induction of let-7 expression in the presence of Lin28 in P14<sup>+</sup>let-7TgLin28Tg (4 Tg) CTLs reduced the expression of <italic>Eomes</italic> (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), demonstrating that the Lin28-mediated knockdown of let-7 miRNAs results in increased expression of <italic>Eomes</italic> in Lin28Tg CTLs. Of note, we also found that T-bet expression was inversely correlated with Eomes, suggesting that an Eomes-dependent mechanism may control T-bet expression (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>). Thus, these results demonstrate that let-7 miRNAs negatively regulate <italic>Eomes</italic> expression.<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.016</object-id><label>Figure 5.</label><caption><title>let-7 miRNAs directly target the mRNA of <italic>Eomes</italic> in activated CD8 T cells.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of <italic>Eomes</italic> (Eomesodermin) and <italic>Tbx21</italic> (T-bet) mRNA in naive and effector CD8 T cells (5 days after anti-CD3 mAb stimulation) generated from wild-type, let-7Tg, and Lin28Tg lymphocytes, presented relative to the ribosomal protein <italic>Rpl13a</italic>. (<bold>B</bold>) Staining of Eomes and T-bet (left) and MFI of Eomes and T-bet (right) in wild-type, let-7Tg and Lin28Tg effector CD8 T cells, normalized to wild-type. (<bold>C</bold>) Quantitative RT-PCR analysis of <italic>Eomes</italic> (Eomesodermin) mRNA in P14<sup>+</sup>wild-type, or P14<sup>+</sup>let-7Tg<sup>+</sup>Lin28Tg<sup>+</sup><italic>Rag2<sup>−/−</sup></italic> (4Tg) lymph nodes cultured either in the presence or absence of Dox, presented as the fold change in expression, normalized to wild-type. (<bold>D</bold>) <italic>Eomes</italic> mRNA, including the 5’ and 3’ untranslated regions (UTR) and the open-reading frame (ORF) within which one let-7-binding site was identified (top), sequence conservation between the mouse and human let-7-binding sites of Eomes is shown (middle). Mutated sequence of the let-7-binding site in the cDNA of mouse Eomes (bottom) used in the luciferase reporter assay. (<bold>E</bold>) Luciferase reporter assay of let-7 targeting of the Eomes ORF in NIH 3T3 fibroblasts transfected with a luciferase reporter containing either the intact or mutated sequence of the let-7 seed region from the mouse Eomes ORF; the activity of firefly luciferase was normalized to the Renilla luciferase control. n.s., not significant (p&gt;0.05), *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001, compared with wild-type using two-tailed Student’s <italic>t</italic>-test. Data are from one experiment representative of three independent experiments (a, b, c, e; mean and s.e.m. of technical triplicates (<bold>A,C,E</bold>) or three experiments (<bold>B</bold>)).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.016">http://dx.doi.org/10.7554/eLife.26398.016</ext-link></p><p><supplementary-material id="SD5-data"><object-id pub-id-type="doi">10.7554/eLife.26398.017</object-id><label>Figure 5—source data 1.</label><caption><title>Quantification of luciferase activity, and the expression of transcription factors in CTLs assessed by flow cytometry and qPCR.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.017">http://dx.doi.org/10.7554/eLife.26398.017</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.018</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Effect of let-7 miRNAs on expression of transcription factors in effector CD8 T cells.</title><p>(<bold>A, B</bold>) Quantitative RT-PCR analysis of Notch target genes: <italic>Hes1</italic> (Hes family BHLH transcription factor 1), <italic>Hey1</italic> (Hes related family BHLH transcription factor with YRPW motif 1), <italic>Heyl</italic> (Hes related family BHLH transcription factor with YRPW motif- like), <italic>Dtx1</italic> (Deltex 1) (<bold>A</bold>) and transcription factors that control CD8 T cell differentiation: <italic>Zbtb32</italic> (Zinc finger and BTB domain containing 32), <italic>Prdm1</italic> (Blimp-1), <italic>Runx3d</italic> (Runt related transcription factor three distal) (<bold>B</bold>) in naive and effector (5 days after anti-CD3 mAb stimulation) wild-type, let-7Tg, and Lin28Tg CD8 T cells, presented relative to the expression of the ribosomal protein <italic>Rpl13a</italic>. Data are from one experiment representative of three independent experiments (a, b; mean and s.e.m. of technical triplicates). N.D., not determined.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.018">http://dx.doi.org/10.7554/eLife.26398.018</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig5-figsupp1-v2"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.019</object-id><label>Figure 5—figure supplement 2.</label><caption><title>Let-7 expression and luciferase detection in NIH 3T3 fibroblasts.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of individual let-7 miRNAs in NIH 3T3 fibroblasts, presented relative to results obtained for the small nuclear RNA (U6) (<bold>B</bold>) Expression analysis of three let-7 family members by luciferase reporter assay. A firefly luciferase reporter containing either intact or mutated let-7b, let-7g or let-7i antisense seed regions were transfected into NIH 3T3 cells. The activity of firefly luciferase was normalized to the Renilla luciferase control. Data are one experiment representative of three independent experiments (a, b; mean and s.e.m. of technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.019">http://dx.doi.org/10.7554/eLife.26398.019</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig5-figsupp2-v2"/></fig></fig-group></p><p>Next, we wanted to determine whether let-7 miRNAs can target <italic>Eomes</italic> mRNA. Interestingly, there is no let-7-binding site located in the 3’UTR of <italic>Eomes</italic>, but rather a conserved binding motif within the open reading frame of <italic>Eomes</italic> mRNA was identified (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; <xref ref-type="supplementary-material" rid="SD7-data">Supplementary file 1</xref>). To determine whether this binding site is functional, the 10-nucleotide mouse <italic>Eomes</italic>-let-7-binding motif was cloned into a dual luciferase vector. The vector was then transfected into NIH 3T3 fibroblasts, which have high endogenous expression of the let-7 family members (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>). This resulted in a significant decrease in luciferase activity, indicating that let-7 can directly bind <italic>Eomes</italic> (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). When this sequence was mutated, disrupting the let-7-binding site, luciferase activity was restored, confirming that let-7 microRNAs directly target <italic>Eomes</italic> mRNA (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p></sec><sec id="s2-6"><title>let-7 miRNAs suppress CD8 T cell function through targeting <italic>Eomes</italic> mRNA</title><p>To ascertain whether let-7 controlled CD8 T cell differentiation and function through Eomes, we used a loss-of-function approach to knockout Eomes expression in Lin28Tg CTLs, expecting the reduction of enhanced cytotoxicity in let-7-deficient cells. T-cell specific deletion of either one or both alleles of <italic>Eomes</italic> in CTLs generated from P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/wt</sup></italic> Lin28Tg, and P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/fl</sup></italic>Lin28Tg T cells resulted in gradually decreased levels of Eomes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Any residual Eomes expression in CTLs derived from <italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/fl</sup></italic>Lin28Tg mice, was attributed to ‘escapees’ of the conditional knockout. The expression of the effector molecules <italic>Gzma</italic>, and <italic>Prf1</italic> was reduced in a manner consistent with the expression of Eomes, where loss of Eomes ameliorated the enhanced expression of these effector molecules in Lin28Tg effector cells (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>). Interestingly, the expression of Granzyme B was not affected by loss of Eomes expression, suggesting Granzyme B may be more complexly regulated through other let-7-dependent, but Eomes-independent mechanisms (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Ultimately, the loss of Eomes expression resulted in a significant reduction of cytotoxic function, even in the absence of let-7 microRNAs (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) while restored Eomes expression completely rescued both the cytotoxic function and the expression of effector molecules in Eomes-deficient Lin28Tg CTLs (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A,B</xref>). Furthermore, forced expression of the mutated form of Eomes (lacking the let-7-binding motif) in let-7Tg CTLs also enhanced the effector phenotype (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C,D</xref>). These results demonstrate that let-7-mediated suppression of Eomes is in part responsible for the compromised differentiation and cytotoxic function of let-7Tg CTLs in vitro.<fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.26398.020</object-id><label>Figure 6.</label><caption><title>let-7 miRNAs control the differentiation of CTLs through Eomes-dependent and independent mechanisms.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of <italic>Eomes</italic> mRNA, presented as the fold change in expression, normalized to wild-type (left) and MFI of Eomes protein expression, normalized to wild-type (right), from CTLs generated from P14<sup>+</sup><italic>CD4Cre<sup>-</sup>Eomes<sup>fl/wt</sup></italic>, P14<sup>+</sup><italic>CD4Cre<sup>-</sup>Eomes<sup>wt</sup></italic>Lin28Tg, P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/wt</sup></italic>Lin28Tg, and P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/fl</sup></italic>Lin28Tg CD8 T cells. (<bold>B</bold>) Quantitative RT-PCR analysis of <italic>GzmA</italic> (Granzyme A) and <italic>Prf1</italic> (Perforin) mRNA in effector CTLs generated from the indicated mice, presented as the fold change in expression, normalized to wild-type. (<bold>C</bold>) Staining of Granzyme A in CTLs generated from the indicated mice. (<bold>D</bold>) Cytotoxicity assay demonstrating specific target lysis of differentiated P14<sup>+</sup> CTLs from the indicated mice, co-cultured with either LCMV gp33 or LCMV np396 peptide-pulsed splenocytes for 4–5 hr. **p&lt;0.01, and ***p&lt;0.001, compared with Lin28Tg using two-tailed Student’s <italic>t</italic>-test. Data are from one experiment representative of two independent experiments (a; mean and s.e.m. of two experiments; b, d; mean and s.e.m. or technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.020">http://dx.doi.org/10.7554/eLife.26398.020</ext-link></p><p><supplementary-material id="SD6-data"><object-id pub-id-type="doi">10.7554/eLife.26398.021</object-id><label>Figure 6—source data 1.</label><caption><title>Quantification of cytotoxic assays and expression of effector molecules assessed by qPCR and flow cytometry in CTLs.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.021">http://dx.doi.org/10.7554/eLife.26398.021</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.022</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Granzyme B expression is regulated independent of Eomes.</title><p>Staining of Granzyme B in CTLs generated from the indicated mice. n.s., not significant (p&gt;0.05), 4Tg without Dox compared with 4Tg with Dox using two-tailed Student’s <italic>t</italic>-test. Data are from one experiment representative of two independent experiments (mean and s.e.m. of two experiments).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.022">http://dx.doi.org/10.7554/eLife.26398.022</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig6-figsupp1-v2"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.023</object-id><label>Figure 6—figure supplement 2.</label><caption><title>Re-expression of Eomes enhances cytotoxic function of CTLs.</title><p>(<bold>A</bold>) Cytotoxicity assay demonstrating specific target lysis of LCMV gp33 or LCMV np396 peptide-pulsed splenocytes by differentiated P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomesfl<sup>fl/fl</sup></italic>Lin28Tg CTLs transduced with the indicated virus, cells were co-cultured for 4–5 hr. (<bold>B</bold>) Quantitative RT-PCR analysis of <italic>Eomes</italic> (Eomesodermin), <italic>Gzma</italic> (Granzyme A), <italic>Gzmb</italic> (Granzyme B), and <italic>Prf1</italic> (Perforin) expression in CTLs described in a, presented as the fold change in expression, normalized to RV-Empty. (<bold>C</bold>) Visualization of the mutations made to the let-7-binding motif in mouse Eomes ORF to generate the RV-Eomes<sup>MUTANT</sup> (top), and cytotoxicity assay demonstrating specific target lysis of differentiated P14<sup>+</sup>let-7Tg CTLs transduced with the indicated virus, co-cultured with either LCMV gp33 or LCMV np396 peptide-pulsed splenocytes for 4–5 hr (bottom). (<bold>D</bold>) Quantitative RT-PCR analysis of <italic>Eomes</italic> (Eomesodermin), <italic>Gzma</italic> (Granzyme A), <italic>Gzmb</italic> (Granzyme B), and <italic>Prf1</italic> (Perforin) in effector CTLs from c, presented as the fold change in expression, normalized to RV-Empty. n.s., not significant (p&gt;0.05), **p&lt;0.01, ***p&lt;0.001, RV-Eomes or RV-Eomes<sup>MUTANT</sup> compared with RV-Empty using two-tailed Student’s <italic>t</italic>-test (<bold>A, B, C, D</bold>). Data are from one experiment representative of two independent experiments (a, b, c, d; mean and s.e.m. of technical triplicates).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.023">http://dx.doi.org/10.7554/eLife.26398.023</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig6-figsupp2-v2"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26398.024</object-id><label>Figure 6—figure supplement 3.</label><caption><title>Model of let-7- mediated regulation of CD8 T cell differentiation.</title><p>Upon TCR stimulation, let-7 miRNAs are rapidly down-regulated, in order to release the ‘molecular brake’ let-7 places on CD8 T cell differentiation in naive cells. Our study suggests that let-7 miRNAs inhibit clonal expansion and metabolic reprogramming of activated CD8 T cells through inhibition of Myc and other cell cycle controlling factors. Further, our data indicates let-7 also suppresses the acquisition of effector function of CTLs through the direct targeting of Eomes mRNA.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.024">http://dx.doi.org/10.7554/eLife.26398.024</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26398-fig6-figsupp3-v2"/></fig></fig-group></p><p>Thus, our data suggest a model in which the let-7 miRNAs act as a molecular control hub that drives CD8 T cell differentiation and function, in a manner dependent on the magnitude of TCR stimulation (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). Furthermore, we propose that modulation of let-7 miRNA expression in CD8 T cells provides an exciting, novel therapeutic application to control CTL responses.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study has identified a critical role for the let-7 miRNAs in regulating the transition between naive and effector stages of CD8 T cells. Specifically, let-7 expression is high in naive T cells and, when absent, results in increased proliferation and expression of activation markers, which may suggest a loss of the quiescent phenotype in CD8 lymphocytes. Moreover, the entire family of let-7 miRNAs is downregulated upon antigen stimulation through the TCR, which we demonstrated is necessary for the successful progression of CD8 T cell differentiation into CTLs. Therefore, our data suggest that let-7 expression keeps CD8 T cells in a naive state and prevents CTL differentiation, while the magnitude of TCR-mediated downregulation of let-7 expression guides the proliferation, differentiation and the acquisition of effector function of CD8 T cells.</p><p>The importance of miRNAs in the regulation of the immune system has been demonstrated through the deletion of the miRNA processing enzyme, Dicer. In fact, it has been shown that Dicer deficiency promotes the differentiation of CD8 T cells into CTLs (<xref ref-type="bibr" rid="bib66">Trifari et al., 2013</xref>), suggesting the involvement of specific miRNAs.</p><p>Let-7 miRNAs, the largest and most abundantly expressed family of miRNAs in CD8 T cells, have been shown to be important in early development, metabolism and cancer (<xref ref-type="bibr" rid="bib81">Zhu et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Abbott et al., 2005</xref>; <xref ref-type="bibr" rid="bib7">Büssing et al., 2008</xref>; <xref ref-type="bibr" rid="bib57">Roush and Slack, 2008</xref>; <xref ref-type="bibr" rid="bib77">Yu et al., 2007</xref>). Recent studies have also implicated the importance of the let-7 miRNAs in the development, maintenance and function of the immune system, including T cells (<xref ref-type="bibr" rid="bib54">Pobezinsky et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Yuan et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Okoye et al., 2014</xref>). Using both gain-of-function experiments employing the let-7Tg mouse capable of sustaining let-7 expression following TCR activation, and loss-of-function experiments using the Lin28Tg mouse, where the Lin28Tg inhibits let-7 expression, our study has corroborated these earlier reports, and has identified a novel role for let-7 in CD8 T cell differentiation and function.</p><p>Prior to antigen encounter, naive CD8 T cells are maintained in a quiescent state, in which T cells have no effector function, are metabolically inactive and undergo minimal proliferation. It has been shown that the homeostasis of naive T cells depends on the balance of two signals, the recognition of low-affinity self-ligands by the TCR, and cytokine stimulation (<xref ref-type="bibr" rid="bib24">Goldrath et al., 2002</xref>; <xref ref-type="bibr" rid="bib36">Kamimura and Bevan, 2007</xref>; <xref ref-type="bibr" rid="bib39">Kieper et al., 2004</xref>, <xref ref-type="bibr" rid="bib38">Kieper et al., 2002</xref>; <xref ref-type="bibr" rid="bib41">Kimura et al., 2013</xref>). Although it has become clear that the weak recognition of self-ligands is not enough for naive T cells to lose the quiescent state, the molecular mechanism that prevents the spontaneous activation of T cells under these conditions is not fully understood. Here, we have demonstrated that the high expression of let-7 miRNAs is necessary to maintain CD8 T cells in a naive state. In fact, we observed that let-7 ablation in CD8 T cells leads to the loss of the quiescent phenotype, as indicated by more active proliferation, an overall increase of cell size, and the upregulation of activation markers such as CD122, and CD44 (<xref ref-type="bibr" rid="bib15">Cuylen et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Intlekofer et al., 2005</xref>). These experiments were conducted using CD8 T cells from P14<sup>+</sup>Lin28Tg<italic>Rag2<sup>−/−</sup></italic> mice in order to prevent bystander effects from IL-4-producing PLZF<sup>+</sup> cells present in Lin28Tg mice (<xref ref-type="bibr" rid="bib54">Pobezinsky et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Yuan et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Weinreich et al., 2010</xref>). Although further investigation is needed to distinguish between the let-7-dependent and let-7-independent effects of the Lin28 transgene in naive CD8 T cells, we can speculate that high expression of let-7 miRNAs prevents the spontaneous activation of naive T cells. Furthermore, it will be interesting to explore the precise let-7-mediated regulation of transcription programs, such as Foxp1 (<xref ref-type="bibr" rid="bib20">Feng et al., 2011</xref>), that may contribute to the control of CD8 T cell quiescence.</p><p>Furthermore, we have found that the let-7-mediated ‘molecular brake’ is released upon antigen stimulation, due to the profound downregulation of all members of the let-7 miRNA family in activated CD8 T cells in response to TCR stimulation, in a manner proportional to its strength. Using in vivo models to assess both antiviral and antitumor immunity, we have demonstrated the importance of let-7 miRNAs in controlling CD8 T cell-mediated immune responses. Let-7Tg CD8 T cells failed to proliferate in response to acute LCMV infection, and the few let-7Tg cells that did respond exhibited a very weak effector phenotype, suggesting that downregulation of let-7 is critical to both the proliferative burst of antigen-specific CD8 T cells upon encounter with viral antigen, and the differentiation of these cells in vivo. These results were further bolstered by the failure of let-7Tg mice to reject an allogeneic tumor, the P815 mastocytoma. Altogether, our in vivo studies demonstrate the significance of let-7 downregulation in effector CD8 T cells, and suggest a novel level of control of immune responses that can be therapeutically targeted for treatment of infectious diseases, cancer and autoimmunity.</p><p>Antigen stimulation of T cells results in the increased biosynthesis that is needed to support the clonal expansion of antigen specific lymphocytes, and ultimately the acquisition of effector function. The hallmark of this process is a metabolic switch from oxidative phosphorylation to aerobic glycolysis (<xref ref-type="bibr" rid="bib21">Frauwirth et al., 2002</xref>; <xref ref-type="bibr" rid="bib22">Frauwirth and Thompson, 2004</xref>), as well as a concomitant increase in cell size, both of which have been reported to be controlled by Myc (<xref ref-type="bibr" rid="bib12">Chou et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Grumont et al., 2004</xref>), the expression of which is rapidly induced upon antigen stimulation of CD8 T cells (<xref ref-type="bibr" rid="bib75">Williams and Bevan, 2007</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Grumont et al., 2004</xref>). Presumably due to the pro-apoptotic activity of Myc (<xref ref-type="bibr" rid="bib2">Askew et al., 1993</xref>; <xref ref-type="bibr" rid="bib17">Evan et al., 1992</xref>; <xref ref-type="bibr" rid="bib18">Fanidi et al., 1992</xref>), its expression is transient, eventually receding during the later stages of CD8 T cell differentiation (<xref ref-type="bibr" rid="bib5">Best et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Nie et al., 2012</xref>). In our study, we have shown that let-7 suppresses the expression of Myc on the mRNA level, and consequently modulates the function of Myc in CD8 T cells, based on our assessment of established Myc targets, supporting the previous observation of Myc as a non-canonical target of let-7 miRNAs in cancer cells (<xref ref-type="bibr" rid="bib40">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Sampson et al., 2007</xref>). Our results suggest that let-7 likely regulates the metabolic switch in activated CD8 T cells through Myc.</p><p>We also found that the let-7 miRNAs may directly inhibit the proliferation of activated CD8 T cells by suppressing the expression of the cell cycle regulators Cdc25a, Ccnd2 and Cdk6, all of which are known let-7 targets (<xref ref-type="bibr" rid="bib32">Johnson et al., 2007</xref>). Since these factors have also been described as transcriptional targets of Myc (<xref ref-type="bibr" rid="bib6">Bouchard et al., 1999</xref>; <xref ref-type="bibr" rid="bib23">Galaktionov et al., 1996</xref>; <xref ref-type="bibr" rid="bib47">Mateyak et al., 1999</xref>), we cannot rule out the possibility of more complex regulation where let-7 is not solely responsible for controlling their expression.</p><p>Moreover, we demonstrated that let-7-mediated suppression of CD8 T-cell immune responses is also due to modulation of effector function. We noticed that the internal complexity of CTLs generated in vitro was diminished in the presence of forced let-7 expression, and subsequently determined that this was due to a reduction in the number of cytotoxic granules, as well as in the expression of effector molecules. We thus concluded that let-7 functions as a molecular rheostat that quantifies TCR signaling to direct the CTL response upon antigen stimulation, in a similar fashion to other miRNAs, including miR-181 and the miR-17–92 cluster (<xref ref-type="bibr" rid="bib28">Henao-Mejia et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Li et al., 2007</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2012</xref>). These conclusions are supported by a recent study demonstrating that in neonatal mice the residual expression of Lin28B in T lymphocytes skews CD8 T cell differentiation toward an effector phenotype (<xref ref-type="bibr" rid="bib70">Wang et al., 2016</xref>).</p><p>We further wanted to determine the molecular mechanisms through which let-7 acts to inhibit CTL differentiation. We found that <italic>Eomes</italic> is directly regulated by let-7 miRNAs, which can in part explain the block in the differentiation of CD8 T cells with forced let-7 expression. Yet, in contrast to previous studies on the differential roles of Eomes and T-bet in governing CD8 T cell function, we have shown that heightened expression of Eomes in effector T cells may be more important for effector function than previously thought (<xref ref-type="bibr" rid="bib52">Pearce et al., 2003</xref>; <xref ref-type="bibr" rid="bib29">Intlekofer et al., 2005</xref>; <xref ref-type="bibr" rid="bib9">Chang et al., 2014</xref>). In fact, let-7/Eomes double-deficient CTLs had reduced antigen-specific cytotoxicity in vitro. However, our data also suggest that Eomes is only a part of this ‘cytotoxic program’, as deletion of Eomes only reduced cytotoxicity to the levels exhibited by wild-type CTLs, and re-expression of Eomes in let-7Tg CTLs only marginally increased cytotoxicity. These results indicate that other let-7- dependent, but Eomes-independent mechanisms are at play. More experiments are required to elucidate these Eomes-independent mechanisms, and should be enlightening given the suggested redundancy of Eomes activity. Additionally, we have identified Granzyme A as a probable target of Eomes, while also confirming that Perforin, and IFN-γ expression is controlled by Eomes (<xref ref-type="bibr" rid="bib52">Pearce et al., 2003</xref>). These results are consistent with the enhanced cytotoxicity exhibited by Lin28Tg CD8 T cells with increased Eomes expression. We also observed previously reported reciprocal expression between T-bet and Eomes (<xref ref-type="bibr" rid="bib29">Intlekofer et al., 2005</xref>; <xref ref-type="bibr" rid="bib9">Chang et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Nayar et al., 2012</xref>).</p><p>These results clearly demonstrate that downregulation of let-7 upon TCR stimulation is a critical process in the determination of the magnitude of the CD8 T cell response in vivo, as let-7 miRNAs inhibit proliferation and differentiation by targeting cell cycle regulators, affecting metabolic reprogramming through the suppression of Myc, and repression of effector function through Eomes-dependent and -independent mechanisms. Thus, naive CD8 T cells require let-7 miRNAs to remain quiescent, and only upon antigen stimulation through the TCR can this molecular ‘brake’ be released. Based on these results, we propose that let-7 miRNAs act as a molecular control hub that translates TCR signaling to control CD8 T cell differentiation and function.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>C57BL/6J (CD45.2<sup>+</sup>wild type, stock no. 000664), B6.SJL- <italic>Ptprc<sup>a</sup>Pepc<sup>b</sup></italic>/BoyJ (CD45.1<sup>+</sup>wild type, stock no. 002014), B6(Cg)- <italic>Rag2<sup>Tm1.1Cgn</sup></italic>/J (<italic>Rag2<sup>−/−</sup></italic>, stock no. 008449), B6 Tg(CD4-cre)1Cwi/BfluJ (<italic>CD4-Cre</italic>, stock no. 017336), and B6.129S1 (Cg)- <italic>Eomes<sup>tm1.1Bflu</sup></italic>/J (<italic>Eomes<sup>fl/fl</sup></italic>, stock no. 017293) were obtained from the Jackson Laboratory. B6.Cg- <italic>Col1a1<sup>tm3(tetO-Mirlet7g/Mir21)Gqda</sup></italic>/J (let-7g, stock no. 023912) and B6.Cg- <italic>Gt(ROSA)26 Sor<sup>tm1(rtTA*M2)Jae</sup></italic>/J (M2rtTA, stock no. 006965) were also obtained from the Jackson Laboratory and subsequently crossed to generate let-7Tg mice. Mice with the Lin28B transgene (Lin28Tg) driven under the control of the human CD2 promoter (<xref ref-type="bibr" rid="bib54">Pobezinsky et al., 2015</xref>), and B6 Tg(TcrLCMV)327Sdz/JDvs/J (P14) mice were a generous gift from Alfred Singer (NCI, NIH). P14<sup>+</sup> mice, and wild-type C57Bl/6J mice on a <italic>Rag2<sup>−/−</sup></italic> background were crossed to generate wild-type P14<sup>+</sup> mice. Let-7Tg mice, and P14<sup>+</sup> mice were crossed on a <italic>Rag2<sup>−/−</sup></italic> background to generate P14<sup>+</sup> doxycycline-inducible let-7 transgenic mice. Lin28Tg mice were crossed with P14<sup>+</sup> mice on a <italic>Rag2<sup>−/−</sup></italic> background to generate P14<sup>+</sup>Lin28Tg mice. let-7Tg, Lin28Tg, P14<sup>+</sup> mice were crossed on a <italic>Rag2<sup>−/−</sup></italic> background to generate 4Tg mice. <italic>CD4Cre</italic> and <italic>Eomes<sup>fl/fl</sup></italic> mice were crossed to generate mice with a T-cell-specific conditional knockout of Eomes. <italic>CD4Cre</italic>, <italic>Eomes<sup>fl/fl</sup>,</italic> Lin28Tg, and P14<sup>+</sup> mice were crossed to generate Lin28Tg mice with a T-cell-specific deletion of Eomes (P14<sup>+</sup><italic>CD4Cre<sup>+</sup>Eomes<sup>fl/fl</sup></italic>Lin28Tg). Littermates or age and sex-matched mice were used as controls. All breedings were maintained at the University of Massachusetts, Amherst. This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2014–0045, 2014–0065, 2015–0035) of the University of Massachusetts.</p></sec><sec id="s4-2"><title>Doxycycline-mediated induction of let-7 transgene expression</title><p>Experimental mice including control animals (unless specifically stated otherwise) were fed with 2 mg/mL doxycycline in drinking water supplemented with 10 mg/mL sucrose for 4 days prior to the initiation of experimental procedures to ensure maximal induction of let-7g expression. Doxycycline drinking water was replaced every other day. In vitro, lymphocytes were cultured with 2 μg/mL doxycycline in CTL culture media (see cell sorting and in vitro culture below).</p></sec><sec id="s4-3"><title>In vivo BrdU labeling</title><p>Mice were injected i.p. with 1 mg BrdU in PBS, and subsequently fed with 0.8 mg/mL BrdU in drinking water supplemented with 2% sucrose for 4 days. BrdU water was kept in the dark to eliminate light-sensitivity effects of BrdU and was replaced daily. Incorporation of BrdU in CD8 T cells from the spleen and lymph nodes were analyzed by flow cytometry (see flow cytometry analysis below).</p></sec><sec id="s4-4"><title>Flow cytometry analysis</title><p>Flow cytometry data were acquired on a BD Fortessa or a MilliPore Amnis ImageStream. The following monoclonal antibodies were used: CD8α (53–6.7, eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_962672">AB_962672</ext-link>; 5H10, Invitrogen, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10372364">AB_10372364</ext-link>), CD8β (YTS156.7.7, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_961293">AB_961293</ext-link>), CD4 (RM4-5, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312718">AB_312718</ext-link>), BrdU (3D4, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2564481">AB_2564481</ext-link>), CD44 (IM7, BD Pharmingen, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2076224">AB_2076224</ext-link>), CD25 (PC61, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312857">AB_312857</ext-link>; PC61.5 eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465606">AB_465606</ext-link>), CD122 (TM-β1, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_940607">AB_940607</ext-link>), Granzyme A (3G8.5 BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2565309">AB_2565309</ext-link>; eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2573227">AB_2573227</ext-link>), Granzyme B (GB11, BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562195">AB_2562195</ext-link>), IFN- γ (XMG1.2, eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_469503">AB_469503</ext-link>), Eomes (Dan11mag, eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1603275">AB_1603275</ext-link>), Ki67 (SolA15, eBioscience, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11149672">AB_11149672</ext-link>), T-bet (O4-46, BD Pharmingen, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10564093">AB_10564093</ext-link>), PE-Streptavadin (BioLegend, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2571914">AB_2571914</ext-link>).</p><p>For restimulation in vitro, 2 × 10<sup>6</sup> cells were stimulated with phorbol myristate acetate (PMA) and Ionomycin for 4 hr at 37°C and Monensin A for 2 hr at 37°C. Cells were first stained for surface proteins then fixed, permeablized, and stained for intracellular proteins according to the manufacturer’s instructions (BD Pharmingen, eBioscience).</p><p>For LCMV studies, 2 × 10<sup>6</sup> cells were stimulated for 4 hr at 37°C with 2 μg/mL of GP<sub>33-41</sub> or NP<sub>396-404</sub> peptides, and 1 μl/mL GolgiPlug (BD Pharmingen). Cells were first stained for surface proteins then fixed, permeablized, and stained for intracellular proteins according to the manufacturer’s instructions (BD Pharmingen). The following monoclonal antibodies were used: CD8β (YTS156.7.7; BioLegend; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_961293">AB_961293</ext-link>), CD45.1 (A20; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1727488">AB_1727488</ext-link>), CD45.2 (104; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1727491">AB_1727491</ext-link>), KLRG1 (2F1; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393931">AB_393931</ext-link>), CD44 (IM7; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2076224">AB_2076224</ext-link>), TNF-α (MP6-XT22; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_395380">AB_395380</ext-link>), IFN-γ (XMG1.2; BD Pharmingen; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_398551">AB_398551</ext-link>). Flow cytometry data were acquired on a BD LSR II. All flow cytometry data were analyzed with FlowJo software (TreeStar; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008520">SCR_008520</ext-link>). MilliPore Amnis ImageStream data were analyzed with IDEAS software (EMD Millipore).</p></sec><sec id="s4-5"><title>Western blot analysis</title><p>Cells were collected and lysed in M2 lysis buffer (20 mM Tris, pH7.0, 0.5% NP40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM DTT, 05 mM PMSF, 20 mM β-glycerol phosphate, 1 mM sodium vanadate, 1 μg/mL Leupeptin), then resolved by SDS-PAGE. Blots were probed with anti-Perforin (CB5.4, Abcam; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_302236">AB_302236</ext-link>) and anti-actin (AC40, Sigma; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476730">AB_476730</ext-link>), and visualized using enhanced chemiluminescence (ThermoScientific) with horse-radish peroxidase conjugated anti-rat IgG (712-035-150, Jackson ImmunoResearch; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2340638">AB_2340638</ext-link>) or anti-mouse IgG (401215, Calbiochem; RRID_AB:2686924).</p></sec><sec id="s4-6"><title>Cell sorting and in vitro culture</title><p>Lymph nodes were harvested and gently tweezed to remove lymphocytes. CD8 lymph node T cells were enriched for via antibody-mediated depletion of B cells using anti-mouse IgG magnetic beads (BioMag, Qiagen). CD4 T cells were removed via anti-rat IgG magnetic beads (BioMag, Qiagen) following incubation with anti-mouse CD4 antibodies conjugated with rat IgG (GK1.5). Lymphocytes were electronically sorted for the further purification of naive CD8 T cells (CD44<sup>lo</sup> CD25<sup>lo</sup>CD8<sup>+</sup>CD4<sup>-</sup>) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>).</p><p>Cells were stimulated either with irradiated splenocytes loaded with anti-CD3 mAbs (10 μg/mL), or plate-bound anti-TCRβ mAbs (10 μg/mL) and anti-CD28 mAbs (5 μg/mL), then differentiated for 5 days in RPMI supplemented with 10% fetal bovine serum, 1% HEPES, 1% sodium pyruvate, 1% penicillin/streptomycin, 1% L-glutamine, 1% non-essential amino acids, 0.3% β-mercaptoethanol, 100 U/mL IL-2, 100 mg/mL gentamicin, and 2 μg/mL doxycycline when necessary.</p></sec><sec id="s4-7"><title>Eomes site-directed mutagenesis and retroviral transduction</title><p>Site-directed mutagenesis of the let-7 binding site in the Eomes ORF was performed using the Agilent QuikChange II Site-Directed Mutagenesis kit according to the manufacturer’s protocol.</p><p>Retrovirus expressing Eomes or Eomes<sup>MUTANT</sup> cDNA with a GFP reporter were produced from the transfection of PlatE cells using Lipofectamine plus (Invitrogen). For retroviral transduction, naive lymphocytes were stimulated with irradiated splenocytes in the presence of anti-CD3 mAbs (10 μg/mL) for 24 hr, then spin-fected (660 g, 90 min, 30°C) with virus and polybrene (4 μg/mL). Retrovirally transduced cells were obtained by sorting on the GFP<sup>+</sup> population.</p></sec><sec id="s4-8"><title>Prediction of miRNA target</title><p>Eomes was independently identified in an unbiased search of all ORFs in the mouse and human genomes, for matches to an extended 9 bp let-7 seed, 'TACTACCTC'. This search utilized a hashing algorithm as described in (<xref ref-type="bibr" rid="bib46">Markstein et al., 2002</xref>) and identified 119 genes in the mouse genome, and 159 genes in the human genome that have one or more matches to the 9 bp let-7 seed in their ORF sequences. Interestingly, humans have three splice variants of Eomes, one of which lacks the exon containing the match to let-7, thus opening the possibility that Eomes may escape let-7 repression in some cells by alternative splicing of the target sequence. This may require further investigation.</p></sec><sec id="s4-9"><title>Luciferase assay</title><p>NIH 3T3 cells (ATCC) were transfected with the pmirGLO vector (Promega) containing either the intact let-7 binding motif from Eomes, or a mutated version of this binding motif, or either intact antisense or mutated antisense seed regions of let-7b, let-7g, or let-7i using Lipofectamine and Plus reagent (Invitrogen). Luciferase activity was measured 48 hr later on a POLARstar Omega 96-well plate reader (BMG Labtech), using the Dual-Luciferase Reporter Assay System (Promega).</p></sec><sec id="s4-10"><title>CellTrace violet proliferation assay</title><p>Electronically sorted naive CD8 T cells were labeled with CellTrace Violet (Invitrogen) for 15 min at 37°C. Cells were stimulated using plate-bound anti-TCRβ mAbs (10 μg/mL) and anti-CD28 mAbs (5 μg/mL), cultured for 72 hr, and analyzed by flow cytometry.</p></sec><sec id="s4-11"><title>CellTrace violet cytotoxicity assay</title><p>P14<sup>+</sup> CD8 T cells were stimulated with anti-TCRβ mAbs (10 μg/mL) and anti-CD28 mAbs (5 μg/mL) plate-bound antibodies, differentiated into CTLs for 5 days in the presence of IL-2, gentamicin, and 2 μg/mL doxycycline when appropriate. On day 5, live splenocytes were warmed for 10 min at 37°C, then labeled with CellTrace Violet (Invitrogen) at two different concentrations (CTV<sup>high</sup> or CTV<sup>low</sup>) for 15 min at 37°C. CTV<sup>low</sup> splenocytes were then loaded with either LCMV gp33-41 peptide (1 μM, GenScript) or LCMV np396-404 peptide (1 μM, GenScript) for 1 hr at 37°C, and are referred to below as ‘experimental splenocytes’. CTV<sup>high</sup> splenocytes remained peptide-free, and were used as a reference control, referred to below as ‘control splenocytes’. Equal amounts of both experimental and control splenocytes were co-cultured with CTLs at different ratios for 4 to 5 hr. Cytotoxicity was assessed by flow cytometry using propidium iodide.</p><p>Measured as the percent target lysis of live experimental splenocytes loaded with either target (gp33-41) or control (np396-404) peptide from the lymphocytic choriomeningitis virus. The following formula was used to calculate the percent target lysis:<disp-formula id="equ1"><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mi>A</mml:mi><mml:mi>B</mml:mi></mml:mfrac><mml:mi>X</mml:mi><mml:mfrac><mml:mi>C</mml:mi><mml:mi>D</mml:mi></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>X</mml:mi><mml:mtext> </mml:mtext><mml:mn>100</mml:mn></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>A- frequency of live experimental splenocytes co-cultured with CTLs; B- frequency of live control splenocytes co-cultured with CTLs; C- frequency of live control splenocytes incubated in the absence of CTLs; D- frequency of live experimental splenocytes incubated in the absence of CTLs.</p></sec><sec id="s4-12"><title>Lymphocytic choriomeningitis virus infection and T cell adoptive transfer</title><p>10 × 10<sup>3</sup> CD45.2<sup>+</sup> P14<sup>+</sup> donor cells from the indicated mice were transferred i.v. into CD45.1<sup>+</sup> congenic hosts. Mice were inoculated with 5 × 10<sup>4</sup> p.f.u. of LCMV Armstrong i.p.. Spleens were harvested and processed 7 days post- infection.</p></sec><sec id="s4-13"><title>Isolation of RNA and quantitative PCR</title><p>RNA was isolated according to the manufacturer’s instructions (QIAGEN miRNeasy), and genomic DNA removed using the DNA-free DNA removal kit (Ambion). mRNA-encoding cDNA was synthesized using the SuperScript III Reverse Transcriptase kit (Invitrogen), while miRNA- encoding cDNA was synthesized using the Taqman MicroRNA Reverse Transcription kit (Applied Biosystems). SYBR Green quantitative PCR was performed using the Bioline SensiFAST SYBR Lo-Rox kit and Taqman quantitative PCR was performed using the Bioline SensiFAST Lo-Rox kit. Both SYBR Green and Taqman amplification primers (Integrated DNA Technologies, or Applied Biosystems) are listed in <xref ref-type="supplementary-material" rid="SD8-data">Supplementary file 2</xref>.</p></sec><sec id="s4-14"><title>Tumor transplantation</title><p>For P815 (ATCC; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_2124">CVCL_2124</ext-link>) survival studies, 30 × 10<sup>6</sup> tumor cells were injected i.p. into host mice. For P815 tumor burden studies, 20 × 10<sup>6</sup> tumor cells were injected i.p. into host mice. Seven days post-injection, tumor burden was assessed by washing the peritoneum with cold PBS and counting the collected cells. For studies involving let-7Tg mice, all mice were fed with doxycycline for the duration of the study. For studies involving adoptive CD8 T cell transfer, 10 × 10<sup>6</sup> naïve CD8 T cells were injected i.v. into P14<sup>+</sup><italic>Rag2<sup>−/−</sup></italic> mice, concurrently with i.p. tumor injection. The P815 cell line was authenticated by analyzing H-2K<sup>d</sup> expression via flow cytometry.</p></sec><sec id="s4-15"><title>Statistical analysis</title><p><italic>p</italic>-Values were determined using a two-tailed Student’s t-test, or one-tailed Student’s t-test where indicated.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank A Singer, X Tai, T Kadakia, F Van Laethem, M Y Kimura, and B A Osborne for critical reading of the manuscript; A Singer for providing reagents, and Lin28Tg and P14 mice; V Lazarevic for providing the plasmid encoding Eomes-GFP and control empty retrovirus; P Markstein and E D’Souza for assistance with the computational analysis of predicted miRNA targets; and G Abbruzzesse for technical help.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>ACW, Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>KAD, Resources, Data curation, Methodology</p></fn><fn fn-type="con" id="con3"><p>CCA, Data curation, Formal analysis, Validation, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>EF, Data curation, Validation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>ASB, Resources, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>MM, Resources, Software, Validation, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>DA, Resources, Formal analysis, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>RMW, Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>ELP, Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>LAP, Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2014-0045, 2014-0065, 2015-0035) of the University of Massachusetts.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD7-data"><object-id pub-id-type="doi">10.7554/eLife.26398.025</object-id><label>Supplementary file 1.</label><caption><title>A list of all genes containing a 9-base pair let-7 binding motif in either the 3’ untranslanted region (UTR) or open reading frame (ORF) from both the mouse and human genomes, where a (+) or (-) demonstrates the orientation of the gene in the genome.</title><p>The ending models are an illustration of the location of the let-7 binding motifs within the human and mouse <italic>Eomes</italic> gene, where red represents exons and pink represents introns.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.025">http://dx.doi.org/10.7554/eLife.26398.025</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="SD8-data"><object-id pub-id-type="doi">10.7554/eLife.26398.026</object-id><label>Supplementary file 2.</label><caption><title>Primer sequences and Taqman Assay catalog numbers.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.26398.026">http://dx.doi.org/10.7554/eLife.26398.026</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-26398-supp2-v2.xlsx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>AL</given-names></name><name><surname>Alvarez-Saavedra</surname><given-names>E</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name><name><surname>Lau</surname><given-names>NC</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name><name><surname>Horvitz</surname><given-names>HR</given-names></name><name><surname>Ambros</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans</article-title><source>Developmental Cell</source><volume>9</volume><fpage>403</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.07.009</pub-id><pub-id pub-id-type="pmid">16139228</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Askew</surname><given-names>DS</given-names></name><name><surname>Ihle</surname><given-names>JN</given-names></name><name><surname>Cleveland</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin</article-title><source>Blood</source><volume>82</volume><fpage>2079</fpage><lpage>2087</lpage><pub-id pub-id-type="pmid">8400257</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backer</surname><given-names>RA</given-names></name><name><surname>Helbig</surname><given-names>C</given-names></name><name><surname>Gentek</surname><given-names>R</given-names></name><name><surname>Kent</surname><given-names>A</given-names></name><name><surname>Laidlaw</surname><given-names>BJ</given-names></name><name><surname>Dominguez</surname><given-names>CX</given-names></name><name><surname>de Souza</surname><given-names>YS</given-names></name><name><surname>van Trierum</surname><given-names>SE</given-names></name><name><surname>van Beek</surname><given-names>R</given-names></name><name><surname>Rimmelzwaan</surname><given-names>GF</given-names></name><name><surname>ten Brinke</surname><given-names>A</given-names></name><name><surname>Willemsen</surname><given-names>AM</given-names></name><name><surname>van Kampen</surname><given-names>AH</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Blander</surname><given-names>JM</given-names></name><name><surname>van Gisbergen</surname><given-names>K</given-names></name><name><surname>Amsen</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A central role for notch in effector CD8(+) T cell differentiation</article-title><source>Nature Immunology</source><volume>15</volume><fpage>1143</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1038/ni.3027</pub-id><pub-id pub-id-type="pmid">25344724</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>MicroRNAs: target recognition and regulatory functions</article-title><source>Cell</source><volume>136</volume><fpage>215</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id><pub-id pub-id-type="pmid">19167326</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>JA</given-names></name><name><surname>Blair</surname><given-names>DA</given-names></name><name><surname>Knell</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Mayya</surname><given-names>V</given-names></name><name><surname>Doedens</surname><given-names>A</given-names></name><name><surname>Dustin</surname><given-names>ML</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation</article-title><source>Nature Immunology</source><volume>14</volume><fpage>404</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/ni.2536</pub-id><pub-id pub-id-type="pmid">23396170</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Thieke</surname><given-names>K</given-names></name><name><surname>Maier</surname><given-names>A</given-names></name><name><surname>Saffrich</surname><given-names>R</given-names></name><name><surname>Hanley-Hyde</surname><given-names>J</given-names></name><name><surname>Ansorge</surname><given-names>W</given-names></name><name><surname>Reed</surname><given-names>S</given-names></name><name><surname>Sicinski</surname><given-names>P</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Eilers</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27</article-title><source>The EMBO Journal</source><volume>18</volume><fpage>5321</fpage><lpage>5333</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.19.5321</pub-id><pub-id pub-id-type="pmid">10508165</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Büssing</surname><given-names>I</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name><name><surname>Grosshans</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>let-7 microRNAs in development, stem cells and cancer</article-title><source>Trends in Molecular Medicine</source><volume>14</volume><fpage>400</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2008.07.001</pub-id><pub-id pub-id-type="pmid">18674967</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cham</surname><given-names>CM</given-names></name><name><surname>Driessens</surname><given-names>G</given-names></name><name><surname>O'Keefe</surname><given-names>JP</given-names></name><name><surname>Gajewski</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells</article-title><source>European Journal of Immunology</source><volume>38</volume><fpage>2438</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1002/eji.200838289</pub-id><pub-id pub-id-type="pmid">18792400</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Molecular regulation of effector and memory T cell differentiation</article-title><source>Nature Immunology</source><volume>15</volume><fpage>1104</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1038/ni.3031</pub-id><pub-id pub-id-type="pmid">25396352</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CZ</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>MicroRNAs modulate hematopoietic lineage differentiation</article-title><source>Science</source><volume>303</volume><fpage>83</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1126/science.1091903</pub-id><pub-id pub-id-type="pmid">14657504</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>OH</given-names></name><name><surname>Shin</surname><given-names>HM</given-names></name><name><surname>Miele</surname><given-names>L</given-names></name><name><surname>Golde</surname><given-names>TE</given-names></name><name><surname>Fauq</surname><given-names>A</given-names></name><name><surname>Minter</surname><given-names>LM</given-names></name><name><surname>Osborne</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Notch regulates cytolytic effector function in CD8+ T cells</article-title><source>The Journal of Immunology</source><volume>182</volume><fpage>3380</fpage><lpage>3389</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802598</pub-id><pub-id pub-id-type="pmid">19265115</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>C</given-names></name><name><surname>Pinto</surname><given-names>AK</given-names></name><name><surname>Curtis</surname><given-names>JD</given-names></name><name><surname>Persaud</surname><given-names>SP</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Pearce</surname><given-names>EL</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Egawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells</article-title><source>Nature Immunology</source><volume>15</volume><fpage>884</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1038/ni.2943</pub-id><pub-id pub-id-type="pmid">25029552</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>BS</given-names></name><name><surname>Nesterova</surname><given-names>TB</given-names></name><name><surname>Thompson</surname><given-names>E</given-names></name><name><surname>Hertweck</surname><given-names>A</given-names></name><name><surname>O'Connor</surname><given-names>E</given-names></name><name><surname>Godwin</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>CB</given-names></name><name><surname>Brockdorff</surname><given-names>N</given-names></name><name><surname>Fisher</surname><given-names>AG</given-names></name><name><surname>Smale</surname><given-names>ST</given-names></name><name><surname>Merkenschlager</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>T cell lineage choice and differentiation in the absence of the RNase III enzyme dicer</article-title><source>The Journal of Experimental Medicine</source><volume>201</volume><fpage>1367</fpage><lpage>1373</lpage><pub-id pub-id-type="doi">10.1084/jem.20050572</pub-id><pub-id pub-id-type="pmid">15867090</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>BS</given-names></name><name><surname>Hertweck</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>O'Connor</surname><given-names>E</given-names></name><name><surname>Graf</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>T</given-names></name><name><surname>Smale</surname><given-names>ST</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Livesey</surname><given-names>FJ</given-names></name><name><surname>Fisher</surname><given-names>AG</given-names></name><name><surname>Merkenschlager</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A role for Dicer in immune regulation</article-title><source>The Journal of Experimental Medicine</source><volume>203</volume><fpage>2519</fpage><lpage>2527</lpage><pub-id pub-id-type="doi">10.1084/jem.20061692</pub-id><pub-id pub-id-type="pmid">17060477</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuylen</surname><given-names>S</given-names></name><name><surname>Blaukopf</surname><given-names>C</given-names></name><name><surname>Politi</surname><given-names>AZ</given-names></name><name><surname>Müller-Reichert</surname><given-names>T</given-names></name><name><surname>Neumann</surname><given-names>B</given-names></name><name><surname>Poser</surname><given-names>I</given-names></name><name><surname>Ellenberg</surname><given-names>J</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Gerlich</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ki-67 acts as a biological surfactant to disperse mitotic chromosomes</article-title><source>Nature</source><volume>535</volume><fpage>308</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1038/nature18610</pub-id><pub-id pub-id-type="pmid">27362226</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>CX</given-names></name><name><surname>Amezquita</surname><given-names>RA</given-names></name><name><surname>Guan</surname><given-names>T</given-names></name><name><surname>Marshall</surname><given-names>HD</given-names></name><name><surname>Joshi</surname><given-names>NS</given-names></name><name><surname>Kleinstein</surname><given-names>SH</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection</article-title><source>The Journal of Experimental Medicine</source><volume>212</volume><fpage>2041</fpage><lpage>2056</lpage><pub-id pub-id-type="doi">10.1084/jem.20150186</pub-id><pub-id pub-id-type="pmid">26503446</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evan</surname><given-names>GI</given-names></name><name><surname>Wyllie</surname><given-names>AH</given-names></name><name><surname>Gilbert</surname><given-names>CS</given-names></name><name><surname>Littlewood</surname><given-names>TD</given-names></name><name><surname>Land</surname><given-names>H</given-names></name><name><surname>Brooks</surname><given-names>M</given-names></name><name><surname>Waters</surname><given-names>CM</given-names></name><name><surname>Penn</surname><given-names>LZ</given-names></name><name><surname>Hancock</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Induction of apoptosis in fibroblasts by c-myc protein</article-title><source>Cell</source><volume>69</volume><fpage>119</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90123-T</pub-id><pub-id pub-id-type="pmid">1555236</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanidi</surname><given-names>A</given-names></name><name><surname>Harrington</surname><given-names>EA</given-names></name><name><surname>Evan</surname><given-names>GI</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cooperative interaction between c-myc and bcl-2 proto-oncogenes</article-title><source>Nature</source><volume>359</volume><fpage>554</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1038/359554a0</pub-id><pub-id pub-id-type="pmid">1406976</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felix</surname><given-names>NJ</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Specificity of T-cell alloreactivity</article-title><source>Nature Reviews Immunology</source><volume>7</volume><fpage>942</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1038/nri2200</pub-id><pub-id pub-id-type="pmid">18007679</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Takata</surname><given-names>H</given-names></name><name><surname>Day</surname><given-names>TJ</given-names></name><name><surname>Willen</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells</article-title><source>Nature Immunology</source><volume>12</volume><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1038/ni.2034</pub-id><pub-id pub-id-type="pmid">21532575</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frauwirth</surname><given-names>KA</given-names></name><name><surname>Riley</surname><given-names>JL</given-names></name><name><surname>Harris</surname><given-names>MH</given-names></name><name><surname>Parry</surname><given-names>RV</given-names></name><name><surname>Rathmell</surname><given-names>JC</given-names></name><name><surname>Plas</surname><given-names>DR</given-names></name><name><surname>Elstrom</surname><given-names>RL</given-names></name><name><surname>June</surname><given-names>CH</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The CD28 signaling pathway regulates glucose metabolism</article-title><source>Immunity</source><volume>16</volume><fpage>769</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00323-0</pub-id><pub-id pub-id-type="pmid">12121659</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frauwirth</surname><given-names>KA</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regulation of T lymphocyte metabolism</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>4661</fpage><lpage>4665</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.8.4661</pub-id><pub-id pub-id-type="pmid">15067038</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galaktionov</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Beach</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cdc25 cell-cycle phosphatase as a target of c-myc</article-title><source>Nature</source><volume>382</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1038/382511a0</pub-id><pub-id pub-id-type="pmid">8700224</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Sivakumar</surname><given-names>PV</given-names></name><name><surname>Glaccum</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>MK</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Butz</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells</article-title><source>The Journal of Experimental Medicine</source><volume>195</volume><fpage>1515</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1084/jem.20020033</pub-id><pub-id pub-id-type="pmid">12070279</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grumont</surname><given-names>R</given-names></name><name><surname>Lock</surname><given-names>P</given-names></name><name><surname>Mollinari</surname><given-names>M</given-names></name><name><surname>Shannon</surname><given-names>FM</given-names></name><name><surname>Moore</surname><given-names>A</given-names></name><name><surname>Gerondakis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The mitogen-induced increase in T cell size involves PKC and NFAT activation of rel/NF-kappaB-dependent c-myc expression</article-title><source>Immunity</source><volume>21</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.004</pub-id><pub-id pub-id-type="pmid">15345217</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>VN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of microRNA biogenesis</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>15</volume><fpage>509</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1038/nrm3838</pub-id><pub-id pub-id-type="pmid">25027649</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>MP</given-names></name><name><surname>Berrebi</surname><given-names>GA</given-names></name><name><surname>Henkart</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A</article-title><source>Journal of Experimental Medicine</source><volume>170</volume><fpage>933</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1084/jem.170.3.933</pub-id><pub-id pub-id-type="pmid">2788710</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henao-Mejia</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Goff</surname><given-names>LA</given-names></name><name><surname>Staron</surname><given-names>M</given-names></name><name><surname>Licona-Limón</surname><given-names>P</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis</article-title><source>Immunity</source><volume>38</volume><fpage>984</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.02.021</pub-id><pub-id pub-id-type="pmid">23623381</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Intlekofer</surname><given-names>AM</given-names></name><name><surname>Takemoto</surname><given-names>N</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Longworth</surname><given-names>SA</given-names></name><name><surname>Northrup</surname><given-names>JT</given-names></name><name><surname>Palanivel</surname><given-names>VR</given-names></name><name><surname>Mullen</surname><given-names>AC</given-names></name><name><surname>Gasink</surname><given-names>CR</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Miller</surname><given-names>JD</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Ryan</surname><given-names>K</given-names></name><name><surname>Russ</surname><given-names>AP</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Orange</surname><given-names>JS</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin</article-title><source>Nature Immunology</source><volume>6</volume><fpage>1236</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1038/ni1268</pub-id><pub-id pub-id-type="pmid">16273099</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iritani</surname><given-names>BM</given-names></name><name><surname>Delrow</surname><given-names>J</given-names></name><name><surname>Grandori</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>I</given-names></name><name><surname>Klacking</surname><given-names>M</given-names></name><name><surname>Carlos</surname><given-names>LS</given-names></name><name><surname>Eisenman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Modulation of T-lymphocyte development, growth and cell size by the myc antagonist and transcriptional repressor Mad1</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>4820</fpage><lpage>4830</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf492</pub-id><pub-id pub-id-type="pmid">12234922</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janković</surname><given-names>V</given-names></name><name><surname>Remus</surname><given-names>K</given-names></name><name><surname>Molano</surname><given-names>A</given-names></name><name><surname>Nikolich-Zugich</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity</article-title><source>The Journal of Immunology</source><volume>169</volume><fpage>1887</fpage><lpage>1892</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.4.1887</pub-id><pub-id pub-id-type="pmid">12165513</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Esquela-Kerscher</surname><given-names>A</given-names></name><name><surname>Stefani</surname><given-names>G</given-names></name><name><surname>Byrom</surname><given-names>M</given-names></name><name><surname>Kelnar</surname><given-names>K</given-names></name><name><surname>Ovcharenko</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Shelton</surname><given-names>J</given-names></name><name><surname>Shingara</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The let-7 microRNA represses cell proliferation pathways in human cells</article-title><source>Cancer Research</source><volume>67</volume><fpage>7713</fpage><lpage>7722</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-1083</pub-id><pub-id pub-id-type="pmid">17699775</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>NS</given-names></name><name><surname>Cui</surname><given-names>W</given-names></name><name><surname>Chandele</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Urso</surname><given-names>DR</given-names></name><name><surname>Hagman</surname><given-names>J</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor</article-title><source>Immunity</source><volume>27</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.07.010</pub-id><pub-id pub-id-type="pmid">17723218</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Hemby</surname><given-names>S</given-names></name><name><surname>Kersh</surname><given-names>E</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Molecular and functional profiling of memory CD8 T cell differentiation</article-title><source>Cell</source><volume>111</volume><fpage>837</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)01139-X</pub-id><pub-id pub-id-type="pmid">12526810</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Xin</surname><given-names>A</given-names></name><name><surname>Belz</surname><given-names>GT</given-names></name><name><surname>Nutt</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses</article-title><source>Immunity</source><volume>31</volume><fpage>283</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.06.021</pub-id><pub-id pub-id-type="pmid">19664942</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamimura</surname><given-names>D</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>1803</fpage><lpage>1812</lpage><pub-id pub-id-type="doi">10.1084/jem.20070543</pub-id><pub-id pub-id-type="pmid">17664293</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>G</given-names></name><name><surname>Pobezinsky</surname><given-names>LA</given-names></name><name><surname>Jeurling</surname><given-names>S</given-names></name><name><surname>Shinzawa</surname><given-names>M</given-names></name><name><surname>Van Laethem</surname><given-names>F</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>T cell receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1</article-title><source>Science Signaling</source><volume>7</volume><elocation-id>ra83</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2005221</pub-id><pub-id pub-id-type="pmid">25161318</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Tan</surname><given-names>JT</given-names></name><name><surname>Bondi-Boyd</surname><given-names>B</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name><name><surname>Ceredig</surname><given-names>R</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells</article-title><source>The Journal of Experimental Medicine</source><volume>195</volume><fpage>1533</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1084/jem.20020067</pub-id><pub-id pub-id-type="pmid">12070281</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Burghardt</surname><given-names>JT</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A role for TCR affinity in regulating naive T cell homeostasis</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.1.40</pub-id><pub-id pub-id-type="pmid">14688307</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HH</given-names></name><name><surname>Kuwano</surname><given-names>Y</given-names></name><name><surname>Srikantan</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Martindale</surname><given-names>JL</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>HuR recruits let-7/RISC to repress c-Myc expression</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>1743</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1101/gad.1812509</pub-id><pub-id pub-id-type="pmid">19574298</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>MY</given-names></name><name><surname>Pobezinsky</surname><given-names>LA</given-names></name><name><surname>Guinter</surname><given-names>TI</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Tai</surname><given-names>X</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death</article-title><source>Nature Immunology</source><volume>14</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1038/ni.2494</pub-id><pub-id pub-id-type="pmid">23242416</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation</article-title><source>Nature Genetics</source><volume>30</volume><fpage>363</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1038/ng865</pub-id><pub-id pub-id-type="pmid">11896390</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancki</surname> <given-names>DW</given-names></name><name><surname>Hsieh</surname><given-names>CS</given-names></name><name><surname>Fitch</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Mechanisms of lysis by cytotoxic T lymphocyte clones. lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes</article-title><source>Journal of Immunology</source><volume>146</volume><fpage>3242</fpage><lpage>3249</lpage><pub-id pub-id-type="pmid">1673149</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QJ</given-names></name><name><surname>Chau</surname><given-names>J</given-names></name><name><surname>Ebert</surname><given-names>PJ</given-names></name><name><surname>Sylvester</surname><given-names>G</given-names></name><name><surname>Min</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Braich</surname><given-names>R</given-names></name><name><surname>Manoharan</surname><given-names>M</given-names></name><name><surname>Soutschek</surname><given-names>J</given-names></name><name><surname>Skare</surname><given-names>P</given-names></name><name><surname>Klein</surname><given-names>LO</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Chen</surname><given-names>CZ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>miR-181a is an intrinsic modulator of T cell sensitivity and selection</article-title><source>Cell</source><volume>129</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.03.008</pub-id><pub-id pub-id-type="pmid">17382377</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Hua</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ</article-title><source>Nature Immunology</source><volume>12</volume><fpage>861</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1038/ni.2073</pub-id><pub-id pub-id-type="pmid">21785411</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markstein</surname><given-names>M</given-names></name><name><surname>Markstein</surname><given-names>P</given-names></name><name><surname>Markstein</surname><given-names>V</given-names></name><name><surname>Levine</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Genome-wide analysis of clustered dorsal binding sites identifies putative target genes in the Drosophila embryo</article-title><source>Proceedings of the National Academy of Sciences</source><volume>99</volume><fpage>763</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1073/pnas.012591199</pub-id><pub-id pub-id-type="pmid">11752406</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateyak</surname><given-names>MK</given-names></name><name><surname>Obaya</surname><given-names>AJ</given-names></name><name><surname>Sedivy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points</article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>4672</fpage><lpage>4683</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.7.4672</pub-id><pub-id pub-id-type="pmid">10373516</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muljo</surname><given-names>SA</given-names></name><name><surname>Ansel</surname><given-names>KM</given-names></name><name><surname>Kanellopoulou</surname><given-names>C</given-names></name><name><surname>Livingston</surname><given-names>DM</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Aberrant T cell differentiation in the absence of Dicer</article-title><source>The Journal of Experimental Medicine</source><volume>202</volume><fpage>261</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1084/jem.20050678</pub-id><pub-id pub-id-type="pmid">16009718</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayar</surname><given-names>R</given-names></name><name><surname>Enos</surname><given-names>M</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Hemmers</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>JK</given-names></name><name><surname>Klein</surname><given-names>U</given-names></name><name><surname>Thomas</surname><given-names>CJ</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TCR signaling via tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation</article-title><source>Proceedings of the National Academy of Sciences</source><volume>109</volume><fpage>E2794</fpage><lpage>E2802</lpage><pub-id pub-id-type="doi">10.1073/pnas.1205742109</pub-id><pub-id pub-id-type="pmid">23011795</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Cui</surname><given-names>K</given-names></name><name><surname>Yamane</surname><given-names>A</given-names></name><name><surname>Resch</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><name><surname>Casellas</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name><name><surname>Levens</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells</article-title><source>Cell</source><volume>151</volume><fpage>68</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.08.033</pub-id><pub-id pub-id-type="pmid">23021216</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okoye</surname><given-names>IS</given-names></name><name><surname>Coomes</surname><given-names>SM</given-names></name><name><surname>Pelly</surname><given-names>VS</given-names></name><name><surname>Czieso</surname><given-names>S</given-names></name><name><surname>Papayannopoulos</surname><given-names>V</given-names></name><name><surname>Tolmachova</surname><given-names>T</given-names></name><name><surname>Seabra</surname><given-names>MC</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells</article-title><source>Immunity</source><volume>41</volume><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.05.019</pub-id><pub-id pub-id-type="pmid">25035954</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>EL</given-names></name><name><surname>Mullen</surname><given-names>AC</given-names></name><name><surname>Martins</surname><given-names>GA</given-names></name><name><surname>Krawczyk</surname><given-names>CM</given-names></name><name><surname>Hutchins</surname><given-names>AS</given-names></name><name><surname>Zediak</surname><given-names>VP</given-names></name><name><surname>Banica</surname><given-names>M</given-names></name><name><surname>DiCioccio</surname><given-names>CB</given-names></name><name><surname>Gross</surname><given-names>DA</given-names></name><name><surname>Mao</surname><given-names>CA</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Cereb</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Reiner</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Control of effector CD8+ T cell function by the transcription factor eomesodermin</article-title><source>Science</source><volume>302</volume><fpage>1041</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1126/science.1090148</pub-id><pub-id pub-id-type="pmid">14605368</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piskounova</surname><given-names>E</given-names></name><name><surname>Polytarchou</surname><given-names>C</given-names></name><name><surname>Thornton</surname><given-names>JE</given-names></name><name><surname>LaPierre</surname><given-names>RJ</given-names></name><name><surname>Pothoulakis</surname><given-names>C</given-names></name><name><surname>Hagan</surname><given-names>JP</given-names></name><name><surname>Iliopoulos</surname><given-names>D</given-names></name><name><surname>Gregory</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms</article-title><source>Cell</source><volume>147</volume><fpage>1066</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.039</pub-id><pub-id pub-id-type="pmid">22118463</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pobezinsky</surname><given-names>LA</given-names></name><name><surname>Etzensperger</surname><given-names>R</given-names></name><name><surname>Jeurling</surname><given-names>S</given-names></name><name><surname>Alag</surname><given-names>A</given-names></name><name><surname>Kadakia</surname><given-names>T</given-names></name><name><surname>McCaughtry</surname><given-names>TM</given-names></name><name><surname>Kimura</surname><given-names>MY</given-names></name><name><surname>Sharrow</surname><given-names>SO</given-names></name><name><surname>Guinter</surname><given-names>TI</given-names></name><name><surname>Feigenbaum</surname><given-names>L</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function</article-title><source>Nature Immunology</source><volume>16</volume><fpage>517</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1038/ni.3146</pub-id><pub-id pub-id-type="pmid">25848867</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polikepahad</surname><given-names>S</given-names></name><name><surname>Knight</surname><given-names>JM</given-names></name><name><surname>Naghavi</surname><given-names>AO</given-names></name><name><surname>Oplt</surname><given-names>T</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><name><surname>Shaw</surname><given-names>C</given-names></name><name><surname>Benham</surname><given-names>AL</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Soibam</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Coarfa</surname><given-names>C</given-names></name><name><surname>Zariff</surname><given-names>A</given-names></name><name><surname>Milosavljevic</surname><given-names>A</given-names></name><name><surname>Batts</surname><given-names>LM</given-names></name><name><surname>Kheradmand</surname><given-names>F</given-names></name><name><surname>Gunaratne</surname><given-names>PH</given-names></name><name><surname>Corry</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Proinflammatory role for let-7 microRNAS in experimental asthma</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>30139</fpage><lpage>30149</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.145698</pub-id><pub-id pub-id-type="pmid">20630862</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhart</surname><given-names>BJ</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name><name><surname>Basson</surname><given-names>M</given-names></name><name><surname>Pasquinelli</surname><given-names>AE</given-names></name><name><surname>Bettinger</surname><given-names>JC</given-names></name><name><surname>Rougvie</surname><given-names>AE</given-names></name><name><surname>Horvitz</surname><given-names>HR</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans</article-title><source>Nature</source><volume>403</volume><fpage>901</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1038/35002607</pub-id><pub-id pub-id-type="pmid">10706289</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roush</surname><given-names>S</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The let-7 family of microRNAs</article-title><source>Trends in Cell Biology</source><volume>18</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.07.007</pub-id><pub-id pub-id-type="pmid">18774294</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutishauser</surname><given-names>RL</given-names></name><name><surname>Martins</surname><given-names>GA</given-names></name><name><surname>Kalachikov</surname><given-names>S</given-names></name><name><surname>Chandele</surname><given-names>A</given-names></name><name><surname>Parish</surname><given-names>IA</given-names></name><name><surname>Meffre</surname><given-names>E</given-names></name><name><surname>Jacob</surname><given-names>J</given-names></name><name><surname>Calame</surname><given-names>K</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties</article-title><source>Immunity</source><volume>31</volume><fpage>296</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.05.014</pub-id><pub-id pub-id-type="pmid">19664941</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>VB</given-names></name><name><surname>Rong</surname><given-names>NH</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Aris</surname><given-names>V</given-names></name><name><surname>Soteropoulos</surname><given-names>P</given-names></name><name><surname>Petrelli</surname><given-names>NJ</given-names></name><name><surname>Dunn</surname><given-names>SP</given-names></name><name><surname>Krueger</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in burkitt lymphoma cells</article-title><source>Cancer Research</source><volume>67</volume><fpage>9762</fpage><lpage>9770</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2462</pub-id><pub-id pub-id-type="pmid">17942906</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>HM</given-names></name><name><surname>Kapoor</surname><given-names>V</given-names></name><name><surname>Welsh</surname><given-names>R</given-names></name><name><surname>Berg</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The transcription factor ZBTB32 negatively regulates CD8+T cell responses during acute and chronic viral infection</article-title><source>The Journal of Immunology</source><volume>192</volume><elocation-id>143.5</elocation-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>DF</given-names></name><name><surname>Thomas</surname><given-names>MF</given-names></name><name><surname>Hu</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Babiarz</surname><given-names>JE</given-names></name><name><surname>Allen</surname><given-names>CD</given-names></name><name><surname>Matloubian</surname><given-names>M</given-names></name><name><surname>Blelloch</surname><given-names>R</given-names></name><name><surname>Ansel</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells</article-title><source>Immunity</source><volume>35</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.07.009</pub-id><pub-id pub-id-type="pmid">21820330</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Seddiki</surname><given-names>N</given-names></name><name><surname>Kaplan</surname><given-names>W</given-names></name><name><surname>Cowley</surname><given-names>MJ</given-names></name><name><surname>Hood</surname><given-names>CL</given-names></name><name><surname>Clancy</surname><given-names>JL</given-names></name><name><surname>Murray</surname><given-names>DD</given-names></name><name><surname>Méndez</surname><given-names>C</given-names></name><name><surname>Gelgor</surname><given-names>L</given-names></name><name><surname>Anderson</surname><given-names>B</given-names></name><name><surname>Roth</surname><given-names>N</given-names></name><name><surname>Cooper</surname><given-names>DA</given-names></name><name><surname>Kelleher</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression</article-title><source>The Journal of Immunology</source><volume>188</volume><fpage>6238</fpage><lpage>6246</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101196</pub-id><pub-id pub-id-type="pmid">22586040</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Costa</surname><given-names>GL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Fathman</surname><given-names>CG</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A novel transcription factor, T-bet, directs Th1 lineage commitment</article-title><source>Cell</source><volume>100</volume><fpage>655</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80702-3</pub-id><pub-id pub-id-type="pmid">10761931</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>SJ</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Stemmann</surname><given-names>C</given-names></name><name><surname>Satoskar</surname><given-names>AR</given-names></name><name><surname>Sleckman</surname><given-names>BP</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells</article-title><source>Science</source><volume>295</volume><fpage>338</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1126/science.1065543</pub-id><pub-id pub-id-type="pmid">11786644</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thimme</surname><given-names>R</given-names></name><name><surname>Appay</surname><given-names>V</given-names></name><name><surname>Koschella</surname><given-names>M</given-names></name><name><surname>Panther</surname><given-names>E</given-names></name><name><surname>Roth</surname><given-names>E</given-names></name><name><surname>Hislop</surname><given-names>AD</given-names></name><name><surname>Rickinson</surname><given-names>AB</given-names></name><name><surname>Rowland-Jones</surname><given-names>SL</given-names></name><name><surname>Blum</surname><given-names>HE</given-names></name><name><surname>Pircher</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation</article-title><source>Journal of Virology</source><volume>79</volume><fpage>12112</fpage><lpage>12116</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.18.12112-12116.2005</pub-id><pub-id pub-id-type="pmid">16140789</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trifari</surname><given-names>S</given-names></name><name><surname>Pipkin</surname><given-names>ME</given-names></name><name><surname>Bandukwala</surname><given-names>HS</given-names></name><name><surname>Äijö</surname><given-names>T</given-names></name><name><surname>Bassein</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Martinez</surname><given-names>GJ</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation</article-title><source>Proceedings of the National Academy of Sciences</source><volume>110</volume><fpage>18608</fpage><lpage>18613</lpage><pub-id pub-id-type="doi">10.1073/pnas.1317191110</pub-id><pub-id pub-id-type="pmid">24163352</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbist</surname><given-names>KC</given-names></name><name><surname>Guy</surname><given-names>CS</given-names></name><name><surname>Milasta</surname><given-names>S</given-names></name><name><surname>Liedmann</surname><given-names>S</given-names></name><name><surname>Kamiński</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic maintenance of cell asymmetry following division in activated T lymphocytes</article-title><source>Nature</source><volume>532</volume><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/nature17442</pub-id><pub-id pub-id-type="pmid">27064903</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voehringer</surname><given-names>D</given-names></name><name><surname>Blaser</surname><given-names>C</given-names></name><name><surname>Brawand</surname><given-names>P</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name><name><surname>Hanke</surname><given-names>T</given-names></name><name><surname>Pircher</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Viral infections induce abundant numbers of senescent CD8 T cells</article-title><source>The Journal of Immunology</source><volume>167</volume><fpage>4838</fpage><lpage>4843</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.9.4838</pub-id><pub-id pub-id-type="pmid">11673487</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Dillon</surname><given-names>CP</given-names></name><name><surname>Shi</surname><given-names>LZ</given-names></name><name><surname>Milasta</surname><given-names>S</given-names></name><name><surname>Carter</surname><given-names>R</given-names></name><name><surname>Finkelstein</surname><given-names>D</given-names></name><name><surname>McCormick</surname><given-names>LL</given-names></name><name><surname>Fitzgerald</surname><given-names>P</given-names></name><name><surname>Chi</surname><given-names>H</given-names></name><name><surname>Munger</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The transcription factor myc controls metabolic reprogramming upon T lymphocyte activation</article-title><source>Immunity</source><volume>35</volume><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.09.021</pub-id><pub-id pub-id-type="pmid">22195744</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wissink</surname><given-names>EM</given-names></name><name><surname>Watson</surname><given-names>NB</given-names></name><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Rudd</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fetal and adult progenitors give rise to unique populations of CD8+ T cells</article-title><source>Blood</source><volume>128</volume><fpage>3073</fpage><lpage>3082</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-06-725366</pub-id><pub-id pub-id-type="pmid">28034872</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>PS</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Signaling in control of cell growth and metabolism</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a006783</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a006783</pub-id><pub-id pub-id-type="pmid">22687276</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinreich</surname><given-names>MA</given-names></name><name><surname>Odumade</surname><given-names>OA</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells</article-title><source>Nature Immunology</source><volume>11</volume><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1038/ni.1898</pub-id><pub-id pub-id-type="pmid">20601952</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Memory CD8 T-cell differentiation during viral infection</article-title><source>Journal of Virology</source><volume>78</volume><fpage>5535</fpage><lpage>5545</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.11.5535-5545.2004</pub-id><pub-id pub-id-type="pmid">15140950</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wightman</surname><given-names>B</given-names></name><name><surname>Ha</surname><given-names>I</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans</article-title><source>Cell</source><volume>75</volume><fpage>855</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90530-4</pub-id><pub-id pub-id-type="pmid">8252622</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Effector and memory CTL differentiation</article-title><source>Annual Review of Immunology</source><volume>25</volume><fpage>171</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.25.022106.141548</pub-id><pub-id pub-id-type="pmid">17129182</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Wieland</surname><given-names>A</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Davis</surname><given-names>CW</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Hale</surname><given-names>JS</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation</article-title><source>Proceedings of the National Academy of Sciences</source><volume>109</volume><fpage>9965</fpage><lpage>9970</lpage><pub-id pub-id-type="doi">10.1073/pnas.1207327109</pub-id><pub-id pub-id-type="pmid">22665768</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Gong</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>F</given-names></name><name><surname>Lieberman</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>let-7 regulates self renewal and tumorigenicity of breast cancer cells</article-title><source>Cell</source><volume>131</volume><fpage>1109</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.054</pub-id><pub-id pub-id-type="pmid">18083101</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>CK</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kanellopoulou</surname><given-names>C</given-names></name><name><surname>Muljo</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis</article-title><source>Science</source><volume>335</volume><fpage>1195</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1126/science.1216557</pub-id><pub-id pub-id-type="pmid">22345399</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Corbett</surname><given-names>AJ</given-names></name><name><surname>Brady</surname><given-names>JL</given-names></name><name><surname>Sutherland</surname><given-names>RM</given-names></name><name><surname>Lew</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation</article-title><source>The Journal of Immunology</source><volume>165</volume><fpage>3612</fpage><lpage>3619</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.165.7.3612</pub-id><pub-id pub-id-type="pmid">11034363</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dicer controls CD8+ T-cell activation, migration, and survival</article-title><source>Proceedings of the National Academy of Sciences</source><volume>107</volume><fpage>21629</fpage><lpage>21634</lpage><pub-id pub-id-type="doi">10.1073/pnas.1016299107</pub-id><pub-id pub-id-type="pmid">21098294</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Shyh-Chang</surname><given-names>N</given-names></name><name><surname>Segrè</surname><given-names>AV</given-names></name><name><surname>Shinoda</surname><given-names>G</given-names></name><name><surname>Shah</surname><given-names>SP</given-names></name><name><surname>Einhorn</surname><given-names>WS</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Hagan</surname><given-names>JP</given-names></name><name><surname>Kharas</surname><given-names>MG</given-names></name><name><surname>Urbach</surname><given-names>A</given-names></name><name><surname>Thornton</surname><given-names>JE</given-names></name><name><surname>Triboulet</surname><given-names>R</given-names></name><name><surname>Gregory</surname><given-names>RI</given-names></name><collab>DIAGRAM Consortium</collab><collab>MAGIC Investigators</collab><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Lin28/let-7 axis regulates glucose metabolism</article-title><source>Cell</source><volume>147</volume><fpage>81</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.08.033</pub-id><pub-id pub-id-type="pmid">21962509</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.26398.027</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dustin</surname><given-names>Michael L</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells through regulation of Myc and Eomes&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>You set out to demonstrate that the let-7 family of microRNAs play a role in differentiation of mouse cytotoxic CD8 T cells, and propose Myc and Eomesdermin (Eomes) as direct down-stream targets. Overall, both reviewers feel that the work was well done, but that some improvements are required to strengthen your conclusions.</p><p>Essential revisions:</p><p>1) Can the Lin28 effect be overcome with Let-7? There is precedence for Let-7-independent roles of Lin28. This would affect central point of their paper.</p><p>2) Are effects of Lin28 cell intrinsic? In <xref ref-type="fig" rid="fig2">Figure 2</xref>, separate groups of WT and let-7 Tg mice were injected with P815 tumors and the let-7 Tg mice displayed elevated tumor burden and decreased survival. The authors concluded that this was due to CD8 T cell maintenance of let-7 expression, thereby leading to a defective immune response against the tumor. However, from this experimental design, it is impossible to determine whether this is a CD8 T cell intrinsic effect, as let-7g miRNA is maintained in all lymphocytes in the presence of doxycycline. Therefore, forced expression of let-7g may also be impacting the NK or NKT cell response against P815 tumors. Do the authors have any evidence of an impaired CD8 T cell response in this model?</p><p>3) Is the mechanism transcriptional vs post-transcriptional? For example, measure Let-7 precursors in nucleus to see if its transcription or processing?</p><p>4) Controls are important and will make results more convincing.a) authors did not perform global profiling, but only used U6 snRNA to normalize for Let-7 levels; can they get same conclusion using another quantification methods. Authors should consider differences in cell size or total RNA content per cell. b) Relative quantification of mature let-7 levels were determined. However, the way it is presented, one cannot discern the levels of individual let-7 family members, and whether they are decreasing significantly. Ideally, absolute quantification would be done instead of expression relative to one housekeeping small RNA. It would be reassuring to see at least one other miRNA that is unchanged and one that is increased to show that the effect on let-7 expression is specific and not generally observed for all miRNAs upon CD8 T cell activation. It would be reassuring to see at least one other miRNA that is unchanged and one that is increased. c) For mice, what were WT controls? Were they age, microbiome, sex- matched littermates or not? For Dox experiments, were they also given Dox to control for side effects of drug?</p><p>5) Compensation between Eomes and Tbet? This point is also very important since they claim that Eomes is the critical downstream target. They need to strengthen their arguments for this conclusion. Along these lines, can overexpressing Eomes (using synonymous substitution at the seed sequence targeted by let-7) in Eomes fl/fl Lin28 CD4 Cre+ Tg P14 CD8 T cells rescue T cell function?</p><p>6) The authors should be careful about making conclusions about quiescence of CD8 cells based on Ki67 alone and other markers (such as CD44 and CD122). Why would CD44 expression be significantly changed in spleen but not lymph node (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>)? A direct assay of cell quiescence could be used. A direct assay of cell quiescence should be included in the analysis.</p><p>7) Many metabolic genes are differentially expressed in let-7 and lin28 Tg CD8 T cells. Do the authors have any metabolic analyses on a cellular level (such as OCR and ECR measurements with Seahorse) for WT, let-7 and lin28 Tg CD8 T cells that would help substantiate let-7 as a regulator of the metabolic reprograming that occurs in activated CD8 T cells?</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells&quot; for further consideration at <italic>eLife</italic>. Your revised article has been favorably evaluated by Tadatsugu Taniguchi (Senior editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>All reviewers felt that the manuscript was improved by the revision. The data within this manuscript are sufficient to support your model wherein T cell receptor-mediated downregulation of let-7 is important to facilitate CD8 T cell clonal expansion and the acquisition of effector function. Moreover, your discovery that this is at least in part due to derepression of the newly identified let-7 target, Eomes, is an important finding.</p><p>There are still some minor issues that need to be dealt with prior to publication, but its anticipated that these can be addressed without additional experiments.</p><p>You nicely show that mutated Eomes (with a disrupted let-7 binding motif) can increase the cytotoxic function of let-7Tg CTLs. However, a side-by-side comparison using WT-Eomes may have been even more informative. Is this data available? If so this would strengthen conclusions.</p><p>In response to point #1, you wrote: &quot;We found that Let-7 re-expression dramatically suppresses the expression of Eomes and all tested effector molecules in Lin28Tg CTLs.&quot; However, there is no analysis of Myc expression in 4Tg mice. Furthermore, Rao published that Let-7 targets Dicer mRNA and thus impairs global miRNA processing, which also promotes the CTL program. Do the authors have any data on Myc or Dicer? Do you agree that Dicer is an important target in this regard? See Trifari et al.,2013.</p><p>There is still some imprecise language in the paper. You use the term &quot;loss of quiescence&quot; which is not accurate here. BrDU, like Ki67, indicates proliferation; authors should thus comment only on proliferation rather than &quot;loss of quiescence&quot; because the latter suggests a molecular mechanism. For example, it has been reported that Foxp1 is required for enforcing quiescence on naive CD8 T cells, but you don't present any data about that. Similarly, you should not write &quot;exit from the G0 stage of the cell cycle&quot; since they did not have any data about G0 stage of the cell cycle. Furthermore, you like to use the term &quot;let-7 deficiency.&quot; You should not encourage readers to believe that Lin28Tg is equivalent to let-7 deficiency because as discussed already Lin28 most likely affects not only let-7.</p><p>In the Abstract, the phase &quot;let-7 microRNAs as a novel molecular transmitter of TCR signaling&quot; might be read as the opposite of the phenotype. As indicated in <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, let-7 is drawn as a repressor. Thus, rather than a &quot;transmitter&quot;, let-7 stops the signal / acts like a resistor in the circuit. The authors may want to find a term that better reflects the direction of the effect.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.26398.028</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic></p><p><italic>1) Can the Lin28 effect be overcome with Let-7? There is precedence for Let-7-independent roles of Lin28. This would affect central point of their paper.</italic></p><p>We understand the reviewers’ concern and are very happy to address it. Indeed, it has been demonstrated that Lin28 proteins can bind some mRNAs in addition to Let-7 precursors. To test if the observed effects in Lin28Tg CTLs are due to the let-7 deficiency, we have generated P14+Let-7TgLin28TgRag2KO (4Tg) mice where let-7Tg expression can be induced using doxycycline even in the presence of Lin28Tg. In fact, we have found that the forced expression of the let-7Tg in Lin28Tg CTLs dramatically diminishes their cytotoxic activity as it is shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>. In addition to these results, we generated a new <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> and a new <xref ref-type="fig" rid="fig5">Figure 5C</xref> where we analyzed the expression of effector molecules and the transcription factor Eomes in P14+let7TgLin28TgRagKO CTLs in comparison to P14+Lin28TgRagKO CTLs. We found that Let-7 re-expression dramatically suppresses the expression of Eomes and all tested effector molecules in Lin28Tg CTLs. Altogether our data demonstrate that enhanced differentiation of Lin28Tg CTLs is due to the let-7 deficiency. We also revised the text to emphasize our point.</p><p><italic>2) Are effects of Lin28 cell intrinsic?</italic></p><p>This is a very important point. We have previously published (Pobezinsky et al., 2015) that lin28-mediated let-7-deficiency in T cells causes abnormal development of IL-4-producing PLZF+ innate T lymphocytes. To eliminate any bystander effects and indirect influence of the Lin28Tg on T cell repertoire formation during thymic selection, we have generated P14+Lin28TgRag2-/- mice, where only CD8<sup>+</sup> T cells with selected specificity were generated and expressed Lin28 proteins (Lin28Tg is driven by hCD2-cassette that ensures T cell specific expression).</p><p><italic>In <xref ref-type="fig" rid="fig2">Figure 2</xref>, separate groups of WT and let-7 Tg mice were injected with P815 tumors and the let-7 Tg mice displayed elevated tumor burden and decreased survival. The authors concluded that this was due to CD8 T cell maintenance of let-7 expression, thereby leading to a defective immune response against the tumor. However, from this experimental design, it is impossible to determine whether this is a CD8 T cell intrinsic effect, as let-7g miRNA is maintained in all lymphocytes in the presence of doxycycline. Therefore, forced expression of let-7g may also be impacting the NK or NKT cell response against P815 tumors. Do the authors have any evidence of an impaired CD8 T cell response in this model?</italic></p><p>We absolutely agree with the reviewers. To address this critical comment and directly demonstrate that the rejection of the allogeneic P815 tumor in C57BL/6 mice is CD8 dependent, we conducted an additional experiment that is shown in a new <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>. We demonstrated that the survival of P815 (H-2d) tumor bearing Rag2-/-(H-2b) mice was compromised without adoptive transfer of enriched polyclonal population of CD8 T cells (H-2b). Conversely, Rag2-/- mice that received CD8 T cells were fully protected. Thus, our results and the previously published data (Zhan et al., 2000), clearly demonstrated that in WT(H-2b) mice the rejection of allogeneic P815 tumors is CD8 dependent, justifying the appropriate usage of this model in our work. We also changed the text for clarity and added a new citation.</p><p><italic>3) Is the mechanism transcriptional vs post-transcriptional? For example, measure Let-7 precursors in nucleus to see if its transcription or processing?</italic></p><p>Excellent point. In fact, we are actively investigating this matter and our very preliminary data suggest that let-7 expression in T cells is regulated on the post-transcriptional level upon TCR-signaling. However, we think that discussion of this mechanism here will dilute the focus of our paper, which is about let-7 mediated regulation of CD8 differentiation and function, but not let-7 biogenesis. No doubt, it is an important question that requires further detailed investigation.</p><p><italic>4) Controls are important and will make results more convincing.a) authors did not perform global profiling, but only used U6 snRNA to normalize for Let-7 levels; can they get same conclusion using another quantification methods. Authors should consider differences in cell size or total RNA content per cell.</italic></p><p>In response to the reviewer comment, we confirmed let-7 downregulation in activated CD8 T cells using another widely used and suggested housekeeping control RNA for miRNA normalization, snoRNA-135. These results are shown in a new <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>. Additionally, it has been documented already that effector CD8 T cells express lower levels of let-7 miRNAs in comparison to naïve cells (Wu H. et al., PLoS One 2007).</p><p> <italic>b) Relative quantification of mature let-7 levels were determined. However, the way it is presented, one cannot discern the levels of individual let-7 family members, and whether they are decreasing significantly. Ideally, absolute quantification would be done instead of expression relative to one housekeeping small RNA. It would be reassuring to see at least one other miRNA that is unchanged and one that is increased to show that the effect on let-7 expression is specific and not generally observed for all miRNAs upon CD8 T cell activation. It would be reassuring to see at least one other miRNA that is unchanged and one that is increased.</italic></p><p>We agree. In a new <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> we display the expression levels and statistics for each individual let-7 miRNA from the experiments shown on the <xref ref-type="fig" rid="fig1">Figure 1A</xref> and B. In addition, we used snoRNA135 for normalization to validate our results (new <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). We also added expression of a control miRNA, miR-17 that is induced upon TCR-stimulation in CD8 T cells (Katz et al., 2014) (please see a new <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>).</p><p> <italic>c) For mice, what were WT controls? Were they age, microbiome, sex- matched littermates or not? For Dox experiments, were they also given Dox to control for side effects of drug?</italic></p><p>We absolutely agree and apologize for the lack of these details. We clarified this issue in Materials and methods. Briefly, for most of our experiments we used littermates as controls. Age and sex matched C57BL/6 (control) mice were also used when it was appropriate. For “DOX” experiments, we fed ALL mice involved including controls.</p><p><italic>5) Compensation between Eomes and Tbet? This point is also very important since they claim that Eomes is the critical downstream target. They need to strengthen their arguments for this conclusion. Along these lines, can overexpressing Eomes (using synonymous substitution at the seed sequence targeted by let-7) in Eomes fl/fl Lin28 CD4 Cre+ Tg P14 CD8 T cells rescue T cell function?</italic></p><p>We thank reviewers for this suggestion. In <xref ref-type="fig" rid="fig6">Figure 6</xref> we demonstrated that derepression of Eomes in let-7 deficient CTLs causes enhanced cytotoxic function of CTLs. Specifically, we conditionally knocked out Eomes in let-7 deficient CTLs, which reduced the superior cytotoxic function of these cells. Additionally, to address reviewers comment, we overexpressed Eomes (wild type, un-mutated) in CTLs deficient in both let-7 and Eomes generated from P14<sup>+</sup>CD4CRE<sup>+</sup>Eomes<sup>fl/fl</sup>Lin28Tg mice and assessed the phenotype. We found that Eomes re-expression enhanced the cytotoxic response and rescued expression of effector molecules. These results are shown in a new <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A and B</xref>. Furthermore, we also generated and expressed mutEomes (with silence mutation that disrupts the let-7 binding motif in the ORF of Eomes) in Let-7 transgenic CTLs from P14<sup>+</sup>Let-7Tg mice. Surprisingly, we observed only partial increase in the cytotoxic function of let-7Tg CTLs suggesting that let-7 miRNAs control CTL function through Eomes dependent and independent mechanisms. These data are shown in a new <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C and D</xref>.</p><p><italic>6) The authors should be careful about making conclusions about quiescence of CD8 cells based on Ki67 alone and other markers (such as CD44 and CD122). Why would CD44 expression be significantly changed in spleen but not lymph node (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>)? A direct assay of cell quiescence could be used. A direct assay of cell quiescence should be included in the analysis.</italic></p><p>This is a great point. To directly assess the difference in cell cycle progression of naive T cells with and without let-7, we measured BrdU incorporation in vivo and included these results in a new <xref ref-type="fig" rid="fig1">Figure 1E</xref>. Specifically, let-7 deficient cells had a higher frequency of BrdU<sup>+</sup> CD8 T cells in comparison to the WT control. We also improved the statistics in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref> by analyzing more samples, please see a new <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>. Thus, our data demonstrate that let-7 deficiency causes elevated expression of the activation markers, CD44 and CD122 and a significant increase of Ki67+ and BrdU<sup>+</sup> cells in the population of naïve CD8 lymphocytes, suggesting that indeed let-7 controls the quiescent state of naïve CD8 T cells.</p><p><italic>7) Many metabolic genes are differentially expressed in let-7 and lin28 Tg CD8 T cells. Do the authors have any metabolic analyses on a cellular level (such as OCR and ECR measurements with Seahorse) for WT, let-7 and lin28 Tg CD8 T cells that would help substantiate let-7 as a regulator of the metabolic reprograming that occurs in activated CD8 T cells?</italic></p><p>Although we completely agree with the reviewers and understand that these experiments will further improve our manuscript, we are not be able to measure OCR or ECAR in our cells since we have no access to a Seahorse instrument. We also think that the observed let-7 mediated changes in metabolic targets of Myc give us sufficient evidence to at least suggest that let-7 may influence CD8 T cell metabolism through Myc. In order to answer this comment, we changed the wording in the manuscript to emphasize that our data is more speculative/suggestive of a let-7 mediated mechanism of metabolic reprogramming.</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><p><italic>All reviewers felt that the manuscript was improved by the revision. The data within this manuscript are sufficient to support your model wherein T cell receptor-mediated downregulation of let-7 is important to facilitate CD8 T cell clonal expansion and the acquisition of effector function. Moreover, your discovery that this is at least in part due to derepression of the newly identified let-7 target, Eomes, is an important finding.</italic></p><p><italic>There are still some minor issues that need to be dealt with prior to publication, but its anticipated that these can be addressed without additional experiments.</italic></p><p><italic>You nicely show that mutated Eomes (with a disrupted let-7 binding motif) can increase the cytotoxic function of let-7Tg CTLs. However, a side-by-side comparison using WT-Eomes may have been even more informative. Is this data available? If so this would strengthen conclusions.</italic></p><p>We completely agree with the reviewers. Unfortunately, we do not have this additional control, the generation of which would require long term experimental procedures.</p><p><italic>In response to point #1, you wrote: &quot;We found that Let-7 re-expression dramatically suppresses the expression of Eomes and all tested effector molecules in Lin28Tg CTLs.&quot;</italic></p><p>In the previous version of the manuscript the impact of let-7 on the expression of the critical molecule, perforin was tested only on mRNA levels in CTLs. We decided to take the initiative to include the WB analysis of perforin expression on protein levels (please see the new <xref ref-type="fig" rid="fig4">Figure 4G</xref>).</p><p><italic>However, there is no analysis of Myc expression in 4Tg mice.</italic></p><p>We really appreciate the comment. Our analysis of the expression of effector molecules in 4Tg CTLs was intentionally limited to day 5. At this time point (day 5) Myc expression in effector T cells is already gone (Chou et al., 2013). Unfortunately, we do not have RNA samples from early time points of 4Tg CD8 T cell activation to address this comment directly. Conducting this supplementary experiment again with three repeats will require isolation of CD8 T cells from VERY rare 4Tg mice (P14TgLin28TgLet7TgM2rtTATgRAG2KO) in our colony. However, we think that together, published evidence (let-7 targets Myc mRNA) and our data shown in <xref ref-type="fig" rid="fig3">Figure 3C,D</xref>(let-7Tg expression in activated T cells suppresses Myc expression/ function) are sufficient to conclude that let-7 impacts the expression of Myc in activated T cells. Please note that the presence of let-7Tg T cells as an appropriate control that opposes the phenotype of Lin28Tg cells in these experiments leaves little room to doubt our conclusions.</p><p><italic>Furthermore, Rao published that Let-7 targets Dicer mRNA and thus impairs global miRNA processing, which also promotes the CTL program. Do the authors have any data on Myc or Dicer? Do you agree that Dicer is an important target in this regard? See Trifari et al., 2013.</italic></p><p>We thank the reviewers for the interesting point. However, we found that TCR- mediated activation suppresses the expression of all members of let-7 family during T cell differentiation into CTLs. Although we did not analyze Dicer expression, it seems very unlikely that Dicer goes down in activated (let-7 low) T cells due to the let-7 interference. In fact, we think that the enhanced CTL program in dicer deficient cells is due to the absence of let-7 miRNAs (among many others), which further emphasizes our conclusion. We included the last point in our Discussion.</p><p><italic>There is still some imprecise language in the paper. You use the term &quot;loss of quiescence&quot; which is not accurate here. BrDU, like Ki67, indicates proliferation; authors should thus comment only on proliferation rather than &quot;loss of quiescence&quot; because the latter suggests a molecular mechanism. For example, it has been reported that Foxp1 is required for enforcing quiescence on naive CD8 T cells, but you don't present any data about that.</italic></p><p>We agree, we do not know the molecular mechanisms of let-7 mediated impact on the naïve state of CD8 T cells. In fact, this is an exciting future area of investigation for our lab. It is known that naive T cells are in a quiescent state based on cell size, proliferation rate and activation markers. In fact, a similar phenotype was seen in Foxp1 deficient CD8 T cells. We found that Lin28Tg antigen-inexperienced CD8 T cells from LNs have:</p><p>– increased proliferation rate</p><p>– upregulated markers of activation</p><p>– increased cell size</p><p>All these results point towards the let-7 mediated molecular mechanism at play that enforces quiescence in naïve CD8 T cells. Taking under consideration reviewers comments we changed the text and used a more suggestive tone. However, we would still like to use term “loss of quiescence” in the Discussion section of our manuscript.</p><p><italic>Similarly, you should not write &quot;exit from the G0 stage of the cell cycle&quot; since they did not have any data about G0 stage of the cell cycle. Furthermore, you like to use the term &quot;let-7 deficiency.&quot; You should not encourage readers to believe that Lin28Tg is equivalent to let-7 deficiency because as discussed already Lin28 most likely affects not only let-7.</italic></p><p>We agree and changed the text accordingly.</p><p><italic>In the Abstract, the phase &quot;let-7 microRNAs as a novel molecular transmitter of TCR signaling&quot; might be read as the opposite of the phenotype. As indicated in <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, let-7 is drawn as a repressor. Thus, rather than a &quot;transmitter&quot;, let-7 stops the signal / acts like a resistor in the circuit. The authors may want to find a term that better reflects the direction of the effect.</italic> </p><p>Agreed, excellent point. We changed the Abstract.</p></body></sub-article></article>